Swallowing Outcomes Following Primary Surgical Resection ... · surgical resection and free flap...
Transcript of Swallowing Outcomes Following Primary Surgical Resection ... · surgical resection and free flap...
i
Swallowing Outcomes Following Primary Surgical
Resection and Primary Free Flap Reconstruction
for Oral and Oropharyngeal Squamous Cell
Carcinomas: A Systematic Review of Quantitative
Evidence
Stephen Shih-Teng Kao
Master of Clinical Science
Joanna Briggs Institute
Faculty of Health Sciences
The University of Adelaide
Australia
October 2015
ii
Abstract
Background
Dysphagia is still a treatment related morbidity as organ preservation does not always
translate into function preservation despite advances in treatment modalities. The purpose of
this systematic review is to review the swallowing outcomes of patients with oral or
oropharyngeal squamous cell carcinoma following primary surgery with primary free flap
reconstruction with or without adjuvant therapy.
Objectives
The objective of this systematic review is to investigate swallowing outcomes following primary
surgical resection and free flap reconstruction for the treatment of patients with oral and
oropharyngeal squamous cell carcinoma. Dysphagia was evaluated with the use of objective
investigations (Videofluoroscopic swallowing studies, Fibreoptic endoscopic evaluations of
swallowing, Manometry, Gastrostomy dependency, Tracheostomy dependency) and
subjective questionnaires (MD Anderson Dysphagia Inventory, University of Washington
Quality of Life Questionnaire, Functional Oral Intake Score).
Inclusion criteria
This review considered studies which included patients with oral or oropharyngeal squamous
cell carcinoma treated with primary surgical resection and primary surgical reconstruction with
or without adjuvant therapy. Swallowing evaluation was conducted at six months or greater
after curative therapy. Objective outcome measures included gastrostomy dependency,
tracheostomy dependency, penetration-aspiration rates, oral and pharyngeal transit times or
pharyngeal pressure readings measured with either videofluoroscopic swallowing studies or
fibreoptic endoscopic evaluations of swallowing or manometry. Subjective outcomes were
measured with the MD Anderson Dysphagia inventory, University Washington Quality of Life
Questionnaire or Functional Oral Intake Scale.
Methods
A comprehensive search strategy was undertaken across MEDLINE, CINAHL, Embase, and
Scopus. Papers retrieved were assessed by two independent reviewers regarding study
design, study population, interventions, outcome measures, results and conclusions for each
article. Data extracted and analyzed for descriptive studies and findings presented in narrative
form.
iii
Results
15 studies were included in the systematic review, which consisted of eight cohort studies and
seven cases series. Postoperative radiotherapy was associated with worse swallowing
outcomes. Swallowing outcomes following the use of radial forearm free flap and anterolateral
thigh flap were inconclusive. Resections of the oropharynx demonstrated poorer swallowing
outcomes compared with oral cavity resections.
Conclusion
Radiotherapy has been demonstrated to be detrimental to swallowing function following
surgical resection and primary free flap reconstruction. Furthermore, swallowing function was
shown to improve with the use of free flap reconstruction compared with primary closure for
large tumor resections. From these results, a protocol for the identification of patients at low
or high risk of developing dysphagia has been proposed. There is, however, a lack of high
quality primary research regarding swallowing outcomes following primary surgery with
primary free flap reconstruction for oral and oropharyngeal squamous cell carcinoma.
iv
Acknowledgements
I would like to thank my supervisors, Dr Micah Peters and Dr Eng Ooi for their
guidance, feedback and support in completing the Thesis.
I would also like to acknowledge Maureen Bell, research librarian, for helping me
develop a comprehensive search strategy and Dr Sabapathy Krishnan my secondary
reviewer.
I would like to thank Doris, Huei-Jong and Wen-I for their unconditional love and
support. Furthermore, I would like to thank my four sisters (Jennifer, Alice, Rebecca
and Vanessa) for their ongoing support.
v
vi
Table of Contents
CHAPTER 1: INTRODUCTION ................................................................................ 1
1.1. CONTEXT OF THE REVIEW ................................................................................... 1
1.2. EPIDEMIOLOGY OF THE ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA... 1
1.3. ANATOMY OF THE ORAL CAVITY AND OROPHARYNX................................................ 1
1.4. PHYSIOLOGY OF SWALLOWING ............................................................................ 2
1.5. PATHOLOGY OF DYSPHAGIA ................................................................................ 3
1.6. TNM CLASSIFICATION ........................................................................................ 4
1.7. TREATMENT MODALITIES .................................................................................... 5
1.8. SWALLOWING EVALUATIONS ............................................................................... 7
1.9. OVERVIEW OF THE SCIENCE OF EVIDENCE SYNTHESIS ......................................... 11
1.11 REVIEW OBJECTIVE ......................................................................................... 17
1.12. REVIEW QUESTION ......................................................................................... 17
1.13. INCLUSION CRITERIA ...................................................................................... 17
1.13.1. TYPES OF PARTICIPANTS .......................................................................... 17
1.13.2. TYPES OF INTERVENTIONS ........................................................................ 18
1.13.3. OUTCOMES ............................................................................................. 18
1.13.4. TYPES OF STUDIES .................................................................................. 18
CHAPTER 2: METHODS........................................................................................ 19
2.1. SEARCH STRATEGY ......................................................................................... 19
2.2. STUDY SELECTION .......................................................................................... 19
2.3. CRITICAL APPRAISAL ....................................................................................... 20
2.4. DATA EXTRACTION ........................................................................................... 20
2.5. DATA SYNTHESIS ............................................................................................. 21
CHAPTER 3: RESULTS ......................................................................................... 22
3.1. SEARCH RESULTS ............................................................................................ 22
3.2. ASSESSMENT OF METHODOLOGICAL QUALITY ..................................................... 24
3.3. DESCRIPTION OF INCLUDED STUDIES ................................................................. 26
CHAPTER 4: DISCUSSION ................................................................................... 35
4.1. OVERVIEW OF FINDINGS ................................................................................... 35
vii
4.2. LIMITATIONS TO THE STUDY .............................................................................. 40
4.3. IMPLICATIONS FOR PRACTICE ............................................................................ 40
4.4. IMPLICATIONS FOR RESEARCH........................................................................... 41
4.5. CONCLUSION .................................................................................................. 42
REFERENCES ....................................................................................................... 43
APPENDIX I: SEARCH STRATEGY ...................................................................... 50
APPENDIX II: CRITICAL APPRAISAL INSTRUMENTS ........................................ 54
APPENDIX III: DATA EXTRACTION INSTRUMENTS ........................................... 57
APPENDIX IV: AUTHORS CONTACTED .............................................................. 58
APPENDIX V: INCLUDED STUDIES ..................................................................... 59
APPENDIX VI: EXCLUDED STUDIES ON FULL TEXT REVIEW .......................... 62
APPENDIX VII: DYSPHAGIA RISK STRATIFICATION TOOL .............................. 70
1
Chapter 1: Introduction
1.1. Context of the review
Treatment modalities for oral and oropharyngeal squamous cell carcinoma (SCC) have
significantly progressed over recent years, with treatments now aimed at organ preservation
and quality of life as well as survival. Dysphagia is still a treatment related morbidity as organ
preservation does not always translate into function preservation despite advances in
treatment modalities. As swallowing function is an integral part of a patient's quality of life
following cancer treatment, it is of great importance that this issue is thoroughly reviewed. The
purpose of this systematic review is to review the swallowing outcomes of patients with oral
or oropharyngeal squamous cell carcinoma following primary surgery with primary free flap
reconstruction with or without adjuvant therapy. This systematic review strives to identify and
synthesize high quality evidence, with the goal of proposing recommendations for clinical
practice and directing future research.
1.2. Epidemiology of the oral and oropharyngeal squamous cell carcinoma
There are approximately 264,000 cases of oral-cavity malignancies and 136,000 cases of
pharyngeal malignancies diagnosed annually worldwide.2-9 The etiology of oral and
oropharyngeal SCC has been strongly linked to smoking and alcohol use.10, 11 Recently, the
human papilloma virus (HPV) has been linked to the development and rise in incidence of
oropharyngeal SCC. Patients with HPV-positive disease are typically younger, non-smokers
and have a favorable prognosis for long-term survival, compared with their HPV-negative
counter parts.12 Therefore treatment regimes have shifted toward organ preservation
techniques with the goal of improving functional outcomes such as swallowing.
1.3. Anatomy of the oral cavity and oropharynx
The oral cavity extends from the vermillion border of the lips and extends to the palatoglossal
arches. It is enclosed superiorly by the hard palate and inferiorly by the muscles of the floor of
mouth. The palatoglossal arches serve as the boundary between the oral cavity and
oropharynx (Figure 1). The oropharynx extends from the lower border of the soft palate to the
upper border of the epiglottis, including the base of tongue. The posterior and lateral walls of
the oropharynx are formed by the pharyngeal constrictors. Anatomically, malignancies in the
oral cavity can extend into the oropharynx, or vice versa, thus it is important to investigate
malignancies of both regions as treatment of both sites adversely effect swallowing.
2
The oral cavity and oropharynx are lined by mucous membranes moistened by saliva secreted
by the major and minor salivary glands.13 Three paired major salivary glands include the
parotid, submandibular and sublingual glands. The parotid gland is located between the
posterior mandibular ramus and mastoid process of temporal bone. Serous secretions enter
the oral cavity via the Stensen duct. The submandibular glands lie superior to the digastric
muscles and drain a mixture of serous fluid and mucus into the oral cavity via the Wharton
duct. Lastly, the sublingual gland is located anterior to the submandibular gland, inferior to the
oral tongue. It drains mainly mucus via the Wharton duct into the floor of mouth. Minor salivary
glands are located within the submucosa throughout the oral cavity and oropharynx. Saliva
produced from these glands play a large role in the lubrication of the oral cavity and oropharynx
to assist in swallowing.14
Figure 1. Anatomy of the oral cavity and oropharynx15
(Used with the permission from Elsevier Limited, Oxford, UK)
1.4. Physiology of swallowing
Swallowing is a complex process where food is transported from the oral cavity to the stomach.
The process of swallowing is commonly divided into oral, pharyngeal and esophageal stages
according to the location of the bolus.16 During the oral phase, the tongue contracts against
3
the hard palate, acting as a propulsion mechanism transporting the bolus toward the
oropharynx. Sufficient force must be generated by the tongue to drive the food bolus
posteriorly. Resections of the oral tongue causing loss of tongue length and projection, impairs
bolus formation.17 Furthermore, fixation of the oral tongue to the floor of mouth decreases
tongue elevation, thus impairing the bolus being pushed against the roof of the mouth.18, 19
The pharyngeal phase consists of soft palate elevation, which prevents nasal regurgitation,
pharyngeal wall contraction and sequential contractions of the pharyngeal constrictors. The
oropharynx sphincteric closure maintains the posterior oral and oropharyngeal pressure wave
to propulse the bolus forwards in the upper aerodigestive tract. Sufficient sensation and
flexibility of the pharynx in conjunction with adequate lubrication with saliva aids the process
of swallowing. During this phase the vocal cords seal the glottis, the larynx is displaced
anterior-superiorly and the epiglottis seals the laryngeal vestibule. This process prevents
aspiration and directs the food into the esophagus through the upper esophageal sphincter.
Finally, the bolus is transported to the stomach via peristalsis of the esophagus.
1.5. Pathology of dysphagia
Dysphagia, or difficulty swallowing, is a devastating consequence of treatment that effects up
to 50% of head and neck cancer survivors.20 Swallowing impairment following treatment of
head and neck malignancy occurs depending on the treatment modality and structures
involved.
Surgical resections involving the oral cavity or oropharynx can significantly affect swallowing
function, due to removal of fundamental structures involved in swallowing. Studies have shown
resections involving the oral tongue, floor of mouth or hypoglossal nerve result in difficulty
chewing and initiating swallowing.21 As previously stated, resections involving the oral tongue
results in difficulty of bolus formation and propulsion through the oral cavity. The base of
tongue plays a vital role in initiating swallowing and propelling the bolus through the pharynx,
thus any resection involving the tongue base will result in reduced pressure generation
causing delayed initiation of swallow and pharyngeal stasis resulting in aspiration.22 Studies
have demonstrated increased tongue base resection to be associated with poorer swallowing
outcomes.7, 19
Radiotherapy is associated with a range of short and long term side effects. Mucositis is seen
in 30 to 60% of patients receiving radiation therapy to the head and neck region.23 Stomatitis
(superficial ulcers) and mucositis are associated with odynophagia and decreased oral
intake.24 Xerostomia, or dry mouth, secondary to salivary gland hypofunction is a common
4
sequela following radiotherapy.25 Saliva has antimicrobial properties and plays an integral role
in formation of food bolus and lubrication of the oral cavity, orophayngeal and upper
esophageal mucosa.26 Thus, xerostomia is associated with increased rates of oral infection,
dental caries, difficulty speaking and swallowing.27 Intensity modulated radiotherapy has
shown to be effective in delivering the full dose of radiation to the tumor site with decreased
exposure to surrounding healthy tissues, such as salivary glands.28 Muscular fibrosis, is a
feared late effect of radiation therapy, causing decreased range of motion of pharyngeal
structures resulting in increased risk of aspiration. Decreased laryngeal elevation, tongue base
to pharyngeal wall contraction and cricopharyngeal sphincter opening have been observed
following radiotherapy.29 Trismus, or limited mouth opening, occurs following radiotherapy due
to loss of function and range of motion secondary to damage and fibrosis to the muscles of
mastication.30 Reduced mastication leads to poor bolus organization with increased residue,
resulting in increased risk of aspiration and increased bolus transit times.
Chemotherapeutic agents are typically used in conjunction with radiotherapy, and are
associated with a range of adverse side effects. Nausea and vomiting is commonly observed
with chemotherapy with associated anorexia and weight loss. The incidence of mucositis
increases to greater than 90% when chemotherapy is utilized in conjunction with
radiotherapy.23 Radiotherapy-induced mucositis is due to a reactive inflammatory process of
the mucous membranes and chemotherapeutic agents cause direct toxicity to the epithelium.31
Thus, the addition of chemotherapy introduces systemic toxicity and thus exacerbates local
tissue reactions, such as mucositis. Combinations of these symptoms have a cumulative
effect on dysphagia, leading to insufficient nutritional intake, increased rates of aspiration and
adversely affecting quality of life.
1.6. TNM classification
Head and neck cancers are staged according to the International Union Against Cancer
(UICC) TNM Classification of Malignant Tumors Edition 7 or American Joint Committee on
Cancer (AJCC) Staging System Edition 7 (Table 1).32, 33 Components of both these systems
include: tumor size (T), regional lymph node spread (N) and distant metastasis (M). The goal
of the TNM staging system is to assist in planning treatment and aid in prognosis.34 Important
factors not taken into account by the TNM classification system that have a significant impact
on prognosis include biological factors (i.e. p16 status) and smoking history.35 Thus patient
factors along with TNM classification must be utilized together to formulate a treatment plan.
Early stage (I/II) and advanced stage (III/IV) malignancies will have immensely different
treatment regimes ranging from single modality treatment, multiple modality treatment to
5
palliation. Depending on the treatment modality utilized, functional outcomes will vary
greatly.36 Patients undergoing treatment aimed at palliation are more likely to have worsening
dysphagia as treatment would be focused on comfort. Therefore, it is paramount to compare
the swallowing outcomes of varying treatment regimes with malignancies of similar stage.
Table 1. Stage Grouping for all Head and Neck Sites Except the Nasopharynx and Thyroid
Stage Group T Stage N Stage M Stage
0 Tis N0 M0
I T1 N0 M0
II T2 N0 M0
III T3 N0 M0
T1 N1 M0
T2 N1 M0
T3 N1 M0
IVa T4a N0 M0
T4a N1 M0
T1 N2 M0
T2 N2 M0
T3 N2 M0
T4a N2 M0
IVb T4b Any N M0
Any T N3 M0
IVc Any T Any N M1
Tis: Tumor in situ; T: Tumor; N: Node; M: Metastases
(Adapted from AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer-
Verlag New York, www.springeronline.com)37
1.7. Treatment modalities
The prognosis from head and neck cancer is improving with treatment protocols utilizing
surgery, radiotherapy, and chemotherapy. Early cancers (Stage I and II) may be treated with
single modality treatment and advanced cancers (Stage III and IV) are treated with sequential
combinations of therapy to enhance survival outcomes.38 The combination of
chemoradiotherapy has been shown to improve survival outcomes; however, it is associated
with increased long-term toxicity.39 The utilization of surgery in advanced stage malignancy to
remove the primary cancer whilst preserving function is a difficult task, as it traditionally
involves mandibulotomies and defects within the head and neck.7, 40 Surgery is typically the
primary treatment for oral cancers, however, there remains controversy regarding the place of
surgery for oropharyngeal malignancies.41 Step-wise increases in access requirements
ranging from pharyngotomies to extensive mandibular and maxillary resections as a result of
increasing size of the primary lesion, thus greatly affecting swallowing outcomes.42, 43 These
6
extensive procedures are required when primary radiotherapy with or without chemotherapy
are unlikely to cure the patient. In these cases, the best option is surgical resection in
conjunction with adjuvant therapy.44
De-escalation of therapy is a concept currently being investigated to assess whether it is able
to reduce toxicity in the short- and long-term without compromising oncological cure.41 In
patients treated with primary chemoradiotherapy, there should be a reduction in total dose to
areas unaffected by cancer as well as adjacent salivary tissue and pharyngeal muscles.45 For
patients treated with primary surgery, the aim is to avoid adjuvant therapy where possible, with
reduction of dosimetry of radiation to avoid chemotherapy.38
Recent advances in treatment modalities, such as transoral robotic surgery (TORS) and
intensity modulated radiotherapy (IMRT) have been developed to improve functional
outcomes post-treatment without compromising oncological benefit.46 Transoral robotic
surgery allows for more accurate dissection, improved visualization with the ability to navigate
around corners with decreased postoperative complications.47 Intensity modulated
radiotherapy was developed to minimize radiation dosage to normal tissue, without
compromising clinical outcomes. Studies have found decreased rates of trismus compared to
conventional radiotherapy.39 Hutcheson et al published a systematic review demonstrating
lower rates of gastrostomy utilization in patients with oropharyngeal SCC treated with primary
TORS compared with definitive IMRT.48 Conversely, de Almeida and colleagues found similar
oncological and functional outcomes following treatment of early oropharyngeal cancer with
TORS or IMRT.46 Despite these advances, swallowing dysfunction is still a regular occurrence
post-treatment.
Surgical reconstruction techniques with the use of free vascularized flaps allows for
improvement in functional and cosmetic outcomes.49 There has been a paradigm shift toward
reestablishing normal function and appearance, in addition to reliable wound closure.50 This
is evidenced by studies transferring free flaps with their associated nerves, allowing for
additional sensory and motor function.51 Free flaps are typically harvested with their
associated blood vessels from a range of various sites, the most commonly utilized soft tissue
donor sites include the radial forearm and anterolateral thigh. The harvested flaps are
employed to fill in surgical defects to improve tongue bulk and contraction power following
glossectomy and restore continuity between the oral cavity and esophagus for pharyngeal
defects. Primary reconstructions performed at the time of resection allows for rapid restoration
of anatomy and function, with decreased potential for muscular atrophy and fibrosis associated
7
with delayed reconstruction, whereas secondary reconstructions are performed as a separate
procedure following resection. 52
1.8. Swallowing evaluations
Gastrostomy tubes are typically inserted in head and neck cancer patients to assist in
maintaining nutritional status during treatment. Due to the devastating effects of dysphagia, it
is common practice in many institutions to insert gastrostomy tubes prior to treatment to
prevent malnutrition secondary to dysphagia. Studies have shown patients with no oral intake
after two weeks are associated with worse swallowing outcomes, potentially due to
deconditioning and disuse atrophy of pharyngeal muscles.43 Dependence on gastrostomy
feeds to maintain adequate nutrition affects 10-25% of these patients with dysphagia.53 There
is currently no consensus on the definition of long-term gastrostomy dependence, however,
articles have correlated swallowing dysfunction present six months after curative therapy to
be highly predictive of life-long dysphagia with up to 38% of patients requiring permanent
gastrostomy tubes.54-58
Tracheostomies are typically required for airway management and protection following open
resections of oral and oropharyngeal cancers, particularly with free flap reconstructions.
Potential life threatening complications following surgery include airway occlusion and
aspiration, of which tracheostomies are a life-saving adjunct.4 The utilization of tracheostomy
tubes has been associated with dysphagia and aspiration, likely due to alteration of
oropharyngeal anatomical structures and preventing laryngeal elevation with swallowing.59
Due to the minimally invasive approach of TORS for oropharyngeal SCC, tracheostomy
insertion can be avoided in greater than 70% of TORS cases, regardless of adjuvant
therapy.60, 61 Tracheostomy dependence therefore is an important aspect to consider when
investigating swallowing outcomes following treatment of oral and oropharyngeal SCC. Apart
from malnutrition and poor general health, secondary to dysphagia, survivors also report a
decreased quality of life.62 Therefore, it is vital to assess the impact of swallowing function,
objectively and subjectively in this population of individuals.
There are objective and subjective assessments used in assessing dysphagia (Table 2).
However, due to the complexity and multi-factorial processes involved in dysphagia, there is
currently no gold standard approach to the assessment of dysphagia. The governance of
limited clinical resources also plays a role in the selection of swallowing investigations required
for each patient. Depending on the progress of their swallowing proficiency following
treatment, investigations are tailored to their needs. Objective assessments currently utilized
8
include videofluoroscopic swallowing studies (VFSS), fibreoptic endoscopic evaluation of
swallowing (FEES) and manometry. VFSS allows for a functional evaluation of swallowing by
visualization and analysis of events that occur during a swallow. It involves swallowing a
barium paste and radiologically tracking its movements through the alimentary tract. Through
this process, investigators are able to measure and review the movements of various
anatomical structures and track bolus transit times during the phases of swallowing.
Additionally, post-radiation stricture formation can be identified and subsequently managed
with dilatation therapy. FEES involves using a flexible nasoendoscope transnasally for real-
time visualization of laryngeal and pharyngeal structures. Food or liquid boluses can be given
to assist in visualization of bolus residue after the pharyngeal phase of swallowing. This
procedure can be completed by the patient's bedside with nil exposure to radiation. The
combination of a bedside assessment with direct observation, allows for prediction of optimum
food consistency to avoid aspiration. The penetration-aspiration-scale (PAS) is an 8-point
scale commonly used in conjunction with VFSS and FEES to assist in quantifying severity of
aspiration. Kelly et al63 published results showing PAS to be perceived more severely in FEES
than from VFSS, however, the likelihood of aspiration pneumonia requires further
investigation. Manometry allows for quantitative evaluation of impedance and pressures
secondary to pharyngeal contraction and upper esophageal sphincter relaxation. It allows of
identification of abnormal pressure peaks or troughs and failure of peristaltic function.
Pressure flow analysis using manometry and impedance measures are an emerging research
tool to investigate swallowing disorders.64, 65
9
Table 2. Summary of Objective Swallowing Assessments
Evaluation Method Items Assessed Advantages Disadvantages
Videofluoroscopic
Swallowing Study
(VFSS)66
Visualization of
bolus flow
Bolus transit time
Structural movement
of related anatomical
structures
Presence and timing
of aspiration
Non-invasive
procedure
Reproducible
Can assess the
pharyngeal and
esophageal phase
Radiation exposure
Requires
fluoroscopy suite
Functional Endoscopic
Evaluation of Swallowing
(FEES)67
Testing laryngeal
sensitivity
Static and dynamic
evaluation of
structures in the
upper airways
Presence of
aspiration
Bedside examination
Easy to perform
Well tolerated
Economical
Discomfort, gagging
Adverse reactions to
topical anesthetics
Operator dependent
Can only assess
post pharyngeal
swallowing
Manometry68 Upper esophageal
sphincter relaxation
Pharyngeal
peristalsis
Intrabolus pressure
No radiation
exposure
Specialized and
experienced staff
Adverse reactions to
topical anesthetics
Subjective assessments include quality of life and functionality questionnaires. Quality of life
questionnaires consist of emotional and physical functioning in conjunction with the patient’s
perception of their own functional state (Table 3). The MD Anderson Dysphagia inventory
(MDADI) was the first validated and reliable self-administered quality of life questionnaire
designed specifically for evaluating dysphagia in patients with head and neck cancer.69 MDADI
consists of four subscales: global, emotional, functional and physical with a total score ranging
from 0-100, higher scores indicating higher quality of life. The University of Washington Quality
of Life Questionnaire (UW-QoL) is another validated self-administered quality of life and
function questionnaire designed specifically for head and neck cancer patients.70-72 Items
assessed in this questionnaire include: pain, appearance, activity, recreation, swallowing,
chewing, speech, shoulder, taste, saliva, mood and anxiety with each domain scored between
0-100. The questionnaire focuses on the patients’ current health and quality of life within the
past seven days. Both these questionnaires are quick and simple for patients to use and have
been widely utilized by clinicians worldwide. The Functional Oral Intake Scale (FOIS) is an
objective and validated 7-point functionality questionnaire used to assess a patient's oral
intake ability.73 Score of one implies the patient is nil by mouth, and seven represents total
10
oral diet with nil restriction. Due to differing measures utilized between these subjective
assessments, they are not directly comparable with each other.
Table 3. Subjective Questionnaires
Questionnaire Domains Assessed
MD Anderson Dysphagia Inventory
(MDADI)
Global
Emotional
Functional
Physical
University of Washington Quality of Life
Questionnaire (UW-QoL)
Pain
Appearance
Activity
Recreation
Swallowing
Chewing
Speech
Shoulder
Taste
Saliva
Mood
Anxiety
Functional Oral Intake Scale (FOIS)73 1 - Nothing by mouth
2 - Tube dependent with minimal attempts of food
or liquid
3 - Tube dependent with consistent oral intake or
food or liquid
4 - Total oral diet of a single consistency
5 - Total oral diet with multiple consistencies, but
requiring special preparation or compensations
6 - Total oral diet with multiple consistencies
without special preparation, but with specific food
limitations
7 - Total oral diet with no restrictions
The treatment modalities for oral and oropharyngeal SCC has dramatically progressed over
recent years, with treatments now aimed at organ preservation. Despite these new advances,
dysphagia is still a common and devastating side effect as organ preservation does not always
translate into function preservation. There is currently no standardized approach to the
assessment of swallowing dysfunction, which causes difficulty in drawing conclusions from
the current available literature. The purpose of this systematic review is to review the
subjective and objective swallowing outcomes of patients with oral or oropharyngeal SCC
following primary surgery with primary free flap reconstruction with or without adjuvant therapy.
11
Lam and colleagues published a systematic review focusing on speech and swallowing
outcomes following tongue cancer surgery and free flap reconstruction.74 They included
patients with intraoral tongue and base of tongue SCC. They demonstrated preoperative
dysphagia was related to tumor volume, and resection of such tumors were less likely to
recover from normal swallowing. Furthermore, partial glossectomy without tip resection, floor
of mouth or base of tongue resection may not have better swallowing outcomes with free flap
reconstruction compared with primary closure. It was shown that immediate reconstruction of
the tongue was associated with poor swallowing and speech outcomes in the early
postoperative phase, however, function improved to preoperative level at one-year post-
treatment. Dziegielewski published a brief systematic review on gastrostomy dependency
rates six to twelve months following total glossectomy with free flap reconstruction.75 They
found twelve-month gastrostomy dependency rate was 24%. Due to the brevity of the
systematic review, no further information was able to be extracted. This systematic review will
focus on swallowing outcomes following treatment of squamous cell carcinomas in all sub-
sites of the oral cavity and oropharynx. It is important to consider all sub-sites of the oral cavity
and oropharynx as both sites are anatomically related with dysphagia. A preliminary search of
the JBI Database of Systematic Reviews & Implementation Reports, Cochrane Database of
Systematic Reviews, Medline, Embase and CINAHL on 26/03/2015 found no systematic
review protocols or reports that investigate swallowing outcomes following free flap
reconstruction in both oral-cavity and oropharynx SCC.76
1.9. Overview of the science of evidence synthesis
Improvement in survival outcomes from advancements in treatment modalities has led to a
focus on functional outcomes, such as swallowing. Dysphagia is a common occurrence
following the treatment of head and neck cancer with great impacts on the quality of life of
these patients. Therefore, it is of great importance that swallowing outcomes are reviewed
following treatment to assist in monitoring and management of post-treatment dysphagia.
Despite, previous systematic reviews focusing on swallowing outcomes following surgical
resection and primary free flap reconstruction of tongue malignancies, none have focused on
all sub-sites of the oral cavity and oropharynx.74, 75 This systematic review is vital to gain further
insight into the effects of post-treatment dysphagia. It addresses this important post-treatment
consequence by using a comprehensive search strategy to locate the evidence, assessment
of the quality of the primary research, and synthesizing the findings extracted from the best
available evidence on this topic. The aim of this systematic review is to provide evidence useful
in clinical practice, and allow for better counselling of patients pre- and post-treatment of their
oral or oropharyngeal SCC. Ideally, the evidence from this systematic review will inform
12
healthcare policy makers and support the standardization in the evaluation of swallowing
outcomes.
Systematic reviews are considered the cornerstone of medical research as they have a
reproducible and rigorous approach to identifying relevant studies with the best available
evidence.77 There are numerous publications investigating functional outcomes following
treatment of oral and oropharyngeal SCC, however, initial searches revealed a lack of placebo
controlled randomized controlled trials (RCTs) available in this area due to ethical concerns
with randomizing people with cancer to receive placebo treatment. Publications on this topic
are typically conducted in single institutions and report on cohort or case-series studies. As
with RCTs, these study designs also range in methodological quality. When conducted well,
RCTs are generally considered to be of a higher level of evidence than cohort and case series
studies. While the strength of evidence available is considered generally less robust and prone
to greater bias than the evidence of high-quality RCTs, in the absence of RCTs, the best
available evidence is likely to be found in papers reporting the results of cohort and case series
studies.78 A systematic review was chosen as the best method of synthesizing the evidence
from the published literature for use in evidence-based healthcare. Evidence-based
healthcare emphasizes that clinical practice should be directed by the best available
evidence.79 Sackett and his colleagues have defined evidence-based healthcare as decisions
made regarding the care of individual patients to be based on the current best evidence, with
the integration of individual clinical expertise with best available external clinical evidence from
systematic research.80 Systematic reviews utilize a predefined methodology stipulated in a
peer reviewed and published a-priori protocol to systematically and comprehensively locate,
collect and appraise, extract data from, and synthesize the evidence from the most relevant
and highest quality studies.77 The strict methodology pre-defined in the protocol aims to limit
bias, thus synthesizing valid and reliable results. This is achieved with the development of an
a-priori protocol consisting of the review question, inclusion and exclusion criteria with a
predefined methodology. The protocol allows for study transparency and reduces author and
study selection bias.81 Systematic reviews are becoming increasingly important in clinical
practice as they allow clinicians to maintain up to date knowledge on their specialty, assist in
production of clinical guidelines, provide evidence for policy makers to review risks, benefits
and harms of interventions, and guide direction for new research.82 Systematic reviews,
however, are limited by the quality of included studies. Therefore, strict critical appraisal is
required to eliminate low quality studies that have the potential to bias the results. The ultimate
goals of systematic reviews are to provide evidence to assist in implementing evidence-based-
practice by promoting practices that are efficacious and eliminating those that are harmful and
ineffective as well as to direct future research.82
13
Systematic reviews can be classified into qualitative or quantitative reviews depending on the
question posed and the type of evidence extracted. Quantitative methodology was developed
from the study of natural and social sciences and has formed the basis of traditional scientific
methods.83 Quantitative evidence involves the collection of numerical data to establish cause
and effect relationships between two or more variables with the use of statistical models.83
The advantage of quantitative evidence is due to its validity and reliability, in other words,
studies with the same study population, study design and measurement outcomes should
consistently yield the same results.83, 84 It is due to these characteristics of quantitative
methodology that favors its application in surgical research.85 This type of methodology allows
for hypotheses to be tested while minimizing bias when analyzing a group of studies with
similar methodologies in a systematic review.86 In the case of this systematic review, the
swallowing effects of patients with oral or oropharyngeal SCC following surgery and adjuvant
therapies will be reviewed.
This systematic review utilized the Joanna Briggs Institute (JBI) systematic review method and
followed a structured process to achieve synthesized findings from the included studies. The
JBI systematic review method corresponds with the PRISMA statement which encourages
transparent reporting of systematic reviews.1 Rigorous and reproducible methodologies with
clear and transparent reporting are techniques utilized in systematic reviews to assist in
synthesis of results with minimal bias and increased validity.1
The development of an a-priori protocol is a fundamental step in conducting a thorough
systematic review. The research protocol provides a framework for the proposed study to
improve rigor, transparency, and reduce study selection bias.81 It consists of a detailed
background with a clear research question, justification of the proposed study, clear inclusion
and exclusion criteria and a proposed methodology.83 Due to the retrospective nature of
systematic reviews, it is important to establish and document these aspects in advance to
reduce potential for author bias and study duplication.87 The Cochrane Collaboration and
Joanna Briggs Institute both have a peer-review process for all protocols prior to the initiation
of systematic reviews.83 The peer-review process for protocols allows for expert opinion on
the proposed study, and gives authors the opportunity to incorporate changes prior to
undertaking the systematic review.88 Furthermore, the protocol for this systematic review was
developed and presented to a panel of experts in the field in July 2015. The panel meeting
provided an opportunity for clarification of various aspects of the protocol and discussion
regarding the topic. The publication of the systematic review protocol promotes transparency
and allows for peer review of the planned methods.88 Deviations from the protocol should be
14
clearly rationalized with judgement on the effects on bias.87 It is vital to document these
changes, as post hoc changes are highly susceptible to bias. There were no post hoc changes
to the systematic review protocol.
A clear and well documented list of inclusion and exclusion criteria are key components of a
systematic review protocol.83 These criteria should be established during the development of
the protocol to reduce the potential of author bias. Explicit inclusion and exclusion criteria with
clear rationale are required to capture studies relevant to the review objective.87 This is
exceptionally important as precise selection criteria assists in narrowing down pertinent
studies, as it reduces the amount of subjective decisions regarding inclusion and exclusion,
thus increasing reproducibility of the study.83, 87 Significant aspects of the inclusion criteria
include types of participants, types of interventions, outcomes of interest, and types of studies.
83 Population of interest should be clearly defined with patients included having similar stages
of malignancy and surgical resection techniques to decrease the potential for known or
unknown confounding biases. Furthermore, outcomes of interest should be clearly defined
including time of evaluation. As there is no gold standard to the assessment of dysphagia, this
systematic review utilized validated objective and subjective assessments which was clearly
described in the protocol. 76 Additionally, study selection is an important aspect to consider
prior to undertaking the systematic review as not all topics will have high quality evidence
available. Randomized control trials are considered the highest level of evidence source of
experimental research as the randomization and blinding process aims to reduce selection
and confounding biases.89 Despite these advantages of randomized controlled trials they are
not appropriate for all study types. Such as in this topic, the highest level of evidence available
are cohort studies and case-series. Regardless of study design, all identified studies need to
undergo further critical appraisal to review their methodological quality.
A detailed and comprehensive search strategy is required to identify all relevant studies. This
aspect of the systematic review decreases the potential for study selection bias when
compared with traditional literature reviews. Regardless of outcomes, all published and non-
published literature are considered for inclusion, thus decreasing potential for selection and
publication bias.83 A preliminary search is utilized to identify important key words and index
terms to the research topic. Once identified, the thorough search strategy is applied across all
included databases. The reference lists of identified studies are further searched for any
missed literature. Upon inception of the systematic review search strategy, the research
librarian was consulted for further advice. Research librarians are vital to the process of
consolidating a comprehensive search strategy due to their expertise and experience in
database searches.90, 91 The goal of a comprehensive search strategy is to identify all relevant
15
articles for review, as missed research leads to biased and incomplete conclusions. 92
Furthermore, search strategies should be included in the systematic review to increase
transparency for readers. 1 Firstly, this allows the readers to gauge the quality of the search
strategy. Secondly, it allows the search to be reproducible for when the review requires future
updating.93
The titles and abstracts from the studies identified from the comprehensive search of all the
included databases are individually reviewed against the inclusion and exclusion criteria set
in the a-prior protocol.83 Furthermore, the full text screening occurs for studies that meet the
inclusion criteria at the title and abstracts stage. Authors should be contacted where details
are unclear. This thorough process of study selection is required as it brings together literature
that is specific to the review question.83, 87 Thus, conclusions drawn from the systematic review
will be focused and specific to the review question.91 Once the studies that meet all inclusion
criteria are identified, they undergo the process of critical appraisal of methodological quality.
The quality of the systematic reviews are dependent on the quality of included studies, thus
critical appraisal is integral to the process. Critical appraisal of methodology is a practice of
systematically examining literature for the presence of bias and thus the validity of its results.83
Studies with poor methodological quality can greatly distort the overall data, and thus should
be excluded from the review. Critical appraisal is crucial as it allows the reviewers to
distinguish the best available evidence from the vast collection of literature available.93 In the
JBI approach, the critical appraisal process involves two independent reviewers, who have
undergone the JBI Comprehensive Review training, and the utilization of the JBI Critical
Appraisal Instruments (Appendix II).83 The JBI Critical Appraisal Instruments (Appendix II) vary
depending on the type of study, as differing types of studies have unique aspects that have
the potential to increase or decrease bias.83 Two trained independent reviewers along with the
standardized appraisal instruments are required in this process to reduce author bias and
increase reproducibility of the critical appraisal process.83, 94, 95 The use the JBI critical
appraisal instrument allows for a thorough and standardized approach to critical appraisal, as
well as transparency of the procedure.83, 87, 96 The depth of information and minimum
requirements in the methodology must be determined and discussed between reviewers prior
to conduction of independent critical appraisal, as this further decreases the potential for
selection biases.83, 96 Only if the systematic review consists of the best available evidence, will
it be able to facilitate evidence-based health care.80
Once the relevant studies that have met all inclusion criteria and passed the critical appraisal
process for methodological quality, they are included in the systematic review for data
16
extraction. Data extraction is an important step that involves the collection of data and
information relevant to the review objective from the included studies. The results from surgical
quantitative studies were typically derived from calculations with the use of statistical models.
Depending on the research question, the results were presented within summary tables or
Kaplan-Meier curves with associated statistically significant p-values. Ideally, the data
presented should not only provide the numerical results, but also statistical and clinical
significance to better increase transparency. When all the pertinent data was collected, it was
able to be synthesized into meaningful results in the form of a meta-analysis or narrative
summary.
When similar studies are collated together in a systematic review, the results can be combined
to form a meaningful meta-analysis. The goal for a meta-analysis is to increase the overall
sample size, thus improving the statistical power of the analysis and precision of the treatment
effects.97 The synthesis of a meta-analysis depends on the quality and heterogeneity of the
included studies.83 If there is a large variation in characteristics in the included studies,
combining data would yield invalid results. The main outcomes from a meta-analysis are the
measure of effect, confidence interval and degree of heterogeneity.83 Included studies were
weighted depending on which studies provided the most relevant information, as they were
likely to provide results closer to the “true effect”.82 Forest plots are commonly utilized to
summarize the findings of a meta-analysis.82, 91 This graphical demonstration allows for
comparison of results from individual studies as well as the overall outcome. Forest plots which
show studies with varying results may demonstrate elements of heterogeneity.82, 98
Alternatively, heterogeneity can be quantified by a calculation developed by Higgins et al.98 In
situations where heterogeneity is present, the studies should not be combined for meta-
analysis. In circumstances, where meta-analyses are not a valid option, narrative summaries
are employed. This process synthesizes the study findings into conclusions that represent
credible opinion. Outcomes predetermined from the a-priori protocol drive the focus of the
narrative review. Although the data cannot be combined, as in a meta-analysis, the narrative
review provides a broad overview of relevant information from the included studies. The
validity of these findings is therefore dependent on the quality of the included studies. A
protocol driven method of analysis that is transparent allows synthesis of quantitative findings
with the research findings utilized as a useful method for transmission of information to be
used in clinical practice.
This systematic review aims to identify the best available evidence examining the swallowing
outcomes of patients with oral or oropharyngeal SCC treated with primary surgery and primary
free flap reconstruction. Systematic review methodology was chosen for this research
17
question due to its rigorous and reproducible approach to the identification of the best
evidence available. Ultimately, this review aimed to synthesize evidence-based research with
the goal of translating the results into recommendations for clinical practice and direct future
research.99
1.11 Review objective
The objective of this systematic review is to investigate swallowing outcomes following primary
surgical resection and free flap reconstruction for the treatment of patients with oral and
oropharyngeal squamous cell carcinoma.
1.12. Review question
What are the swallowing outcomes of primary surgical resection with primary free flap
reconstruction with or without adjuvant therapy for the treatment of oral or oropharyngeal
squamous cell carcinoma?
1.13. Inclusion criteria
1.13.1. Types of participants
The review sought to include studies with participants aged 18 years of age or older with a
histological diagnosis of oral or oropharyngeal squamous cell carcinoma. To be eligible for
inclusion, patients must have received a histological diagnosis of malignancy and have
received treatment aimed at curative intent with locoregional control at time of swallowing
evaluation. Locoregional control at the time of swallowing evaluation is critical as swallowing
outcomes at this time are recognized to be representative of swallowing function that is not
impaired by the primary cancer.100
Exclusion criteria include patients with mandibular or maxillary involvement requiring osseous
free flap reconstruction, distant metastasis at diagnosis, presence of other malignancies, and
diagnosis of dementia, stroke or neurological disease prior to treatment. Osseous free flap
reconstructions are typically associated with larger primary resections, thus effecting
swallowing outcomes. Dementia, stroke and neurological diseases have potential to cause
dysphagia, and thus will be excluded. Patients with distant metastases and other malignancies
will likely undergo aggressively treatment therapies potentially affecting quality of life scores
and swallowing outcomes.
18
1.13.2. Types of interventions
This review will consider the following interventions:
Primary surgery with primary free flap reconstruction alone
Primary surgery with primary free flap reconstruction with adjuvant therapies
Swallowing outcomes with use of radial forearm free flaps following primary surgical
resection with or without adjuvant therapy
Swallowing outcomes with use of anterolateral thigh flaps following primary surgical
resection with or without adjuvant therapy
1.13.3. Outcomes
The outcomes of interest for this review are related to dysphagia. Evaluation of dysphagia will
be measured at six months, as articles have correlated swallowing dysfunction present six
months after curative therapy to be highly predictive of life-long dysphagia.54, 55 To be
included, studies must have measured dysphagia outcomes objectively with either
gastrostomy dependency, tracheostomy dependency, penetration-aspiration rates, oral and
pharyngeal transit times or pharyngeal pressure readings. These outcomes are to be identified
with either Videofluoroscopic Swallowing Studies (VFSS), Fibreoptic Endoscopic Evaluations
of Swallowing (FEES) or manometry. Subjective outcomes were measured with the MD
Anderson Dysphagia Inventory (MDADI), University of Washington Quality of Life
Questionnaire (UW-QOL) or Functional Oral Intake Scale (FOIS).
1.13.4. Types of studies
This review sought to include both experimental and epidemiological study designs including
randomized controlled trials, non-randomized controlled trials, quasi-experimental, before and
after studies, prospective and retrospective cohort studies, case control studies, and analytical
cross sectional studies. Due to the nature of this topic, there are currently no published
randomised controlled trials due to ethical concerns. Thus in the absence of randomized
controlled trials and quasi-experimental studies, the included studies consisted of cohort
studies and case-series.
19
Chapter 2: Methods
2.1. Search strategy
The search strategy aimed to find both published and unpublished studies. A three-step
search strategy was utilized in this review. An initial limited search of MEDLINE and CINAHL
using the terms "oropharynx squamous cell carcinoma", "oral cavity squamous cell
carcinoma", "dysphagia" and "primary free flap reconstruction." The results from this initial
search were reviewed for relevant articles. Relevant articles were retrieved to identify further
keywords and index terms. These identified keywords and index terms were subsequently
applied across all included databases. Once all relevant keywords and index terms were
identified, assistance from a research librarian was sought to aid in producing a detailed and
comprehensive search strategy for each database (Appendix I).
A second search using all identified keywords and index terms was undertaken across all
included databases. The search strategy was designed to capture and retrieve all research
articles relevant to the research question. Thirdly, the reference list of all selected studies and
articles was searched for additional studies that had not been previously identified in the
search. No further papers were found. Studies with human participants published in English
were considered for inclusion in this review. Studies published from the inception of the
included databases to 26/03/2015 were considered for inclusion in this review.
The initial terms searched to identify the number of relevant studies consisted of
“oropharyngeal squamous cell carcinoma”, “oral cavity squamous cell carcinoma”,
“dysphagia” and “primary free flap reconstruction.” The inclusion of Medical Subject Headings
(MeSH) in PubMed, CINAHL Subheadings in CINAHL and EMTREE in Embase were utilized
to increase the sensitivity of the search strategy. Unpublished studies were searched using
the same search terms as above, in conjunction with MeSH terms. The search terms were
used across the following medical databases:
MEDLINE (PubMed), CINAHL, Embase, and Scopus. Grey literature was sought through
Cochrane Central Register of Controlled Trials (CENTRAL), MedNar and ProQuest.
2.2. Study Selection
This systematic review aimed to identify studies in which swallowing outcomes were the
primary or additional outcome. All identified studies were entered and sorted in EndnoteTM,
into groups based on the database the study was extracted from. Duplicate studies were then
20
removed from the list of studies with assistance from an automated scan conducted in
EndnoteTM. The titles and abstracts of all identified studies were screened and assessed
according to the inclusion and exclusion criteria. Studies that were unclear in their title or
abstracts, regarding inclusion and exclusion criteria, full text was retrieved for further analysis.
Studies that underwent full text screening were organized into subgroups depending on the
reason for exclusion.
2.3. Critical Appraisal
Critical appraisal of the fifteen identified qualitative studies was performed by two independent
reviewers, both post-graduate course candidates, for methodological validity prior to inclusion
in the review using standardized critical appraisal instruments from the Joanna Briggs Institute
Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix II).
During the critical appraisal process, it was identified that confounding biases were present
among all included studies. These confounding factors included malignancies of varying
stages or sub-sites, different surgical access techniques and differing extent of resection.
Strategies of reducing confounding bias include randomization, restriction, matching or
multivariate analysis.101 Multivariate analysis is an effective method for stratifying known
confounding factors, however, this was only present in five of the included studies.3, 4, 6-8 Due
to the included studies consisting cohort and case-series studies with small population
numbers, unknown confounding factors are thus difficult to reduce.
Prior to the critical appraisal the two reviewers agreed to a list of guidelines to resolve potential
issues or disagreements. Prospective studies with ten patients or less conducted at a single
institution were classified as case-series. Any disagreements that arose between the
reviewers regarding methodological assessment criteria or the inclusion/ exclusion of studies
were resolved through discussion.
2.4. Data extraction
Data was extracted from papers included in the review using the standardized data extraction
tool from JBI-MAStARI (Appendix III). The data extracted included population, resection
technique, type of flap utilized, site of malignancy, malignancy stage, adjuvant therapy,
outcome measures and time of evaluation. Extracted data from the included studies were
collected and summarized in Appendix V. If relevant data was missing or incomplete in the
located studies, where feasible, the authors were contacted directly with the request to provide
21
this information (Appendix IV). The study was excluded when the required data could not be
provided.
Of the contacted authors, Hartl et al102 and Longo et al17 both provided raw data for further
analysis. With this additional information, both studies were included in this review.
2.5. Data synthesis
Quantitative data was planned to be pooled into a statistical meta-analysis using JBI-
MAStARI. This however, was not possible due to the heterogeneity between included studies.
The heterogeneity consisted of differing surgical resection techniques, utilization of differing
flaps, malignancies of varying stages and sub-sites. Thus the findings were presented in
narrative form including tables and figures to aid in data presentation and interpretation.
Studies were grouped into patients treated with surgery alone or primary surgery with adjuvant
therapies. Additionally, swallowing outcomes with the use of radial forearm free flap were
compared with anterolateral thigh flap. Swallowing outcomes between oral-cavity squamous
cell carcinoma were compared with oropharyngeal squamous cell carcinoma. The effect of
differing surgical access technique was not reviewed, as it is known invasive mandibulotomies
have worse swallowing outcomes compared with transoral approaches.47
22
Chapter 3: Results
This chapter presents the findings of the systematic review, details of the search results, study
selection, assessment of methodological quality and a detailed description of included studies.
The results of swallowing outcomes are presented according to the type of swallowing
evaluation used.
3.1. Search results
As shown in figure 2 the search identified a total of 699 studies in English. Following removal
of duplicates, 420 studies remained for screening. The titles and abstracts were reviewed
against the inclusion criteria to determine their relevance to the review question and
objectives. Through this process, 270 studies were excluded, leaving 150 studies which were
retrieved in full text for detailed examination. Of the 150 full text articles, 135 studies were
excluded as they did not fully meet the inclusion criteria resulting in the selection of 15 for
critical appraisal (Appendix V). The reasons for the exclusion of each of the 135 studies are
provided in Appendix VI. No studies were excluded after assessment of methodological
quality, which is discussed in the next section. Fifteen studies were included in the systematic
review, of which eight were cohort studies and seven cases series. These search results have
been summarized in the following Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) flow diagram (Figure 2).
23
Figure 2. PRISMA Flow diagram illustrating the process of including and excluding studies
from the systematic review.1 Number of studies found and retrieved
Iden
tifi
cati
on
S
cree
nin
g
Incl
ud
ed
Elig
ibili
ty
Full text retrieved for detailed examination n = 150
Full-text articles excluded, with reasons
n = 135
Reasons:
Incorrect population
n = 44
Incorrect study design n = 2
Incorrect outcome
n = 43
Follow up <6/12 n = 16
Non- Free Flap/Osseous Flap
n = 21
Poster n = 9
Studies Assessed for methodological quality n = 15
Cohort Studies n = 8
Records identified through database searching, English only
n = 699
Records after duplicates removed n = 420
Duplicates excluded n = 279
Studies Included in this review
n = 15
Records excluded after review of title and abstract
n = 270
Case-Series n = 7
24
3.2. Assessment of methodological quality
Following the screening and review of the full text, 15 studies underwent independent critical
appraisal by two reviewers trained in the use of JBI-MAStARI (Appendix III). Eight cohort
studies and seven case-series were reviewed. Any disagreements were resolved by
discussion. All fifteen studies were included in this systematic review.
Cohort Studies:
Methodological quality was similar across all 8 cohort studies included in this review. Question
4, regarding confounding bias was answered “yes” in 5 of the included studies as they had
performed multivariate analyses in an attempt to reduce confounding biases.3, 4, 6-8
Confounding factors such as varying surgical access techniques, cancer stages and sub-sites
occurred across all studies. Surgical heterogeneity is a common occurrence in surgical
studies, and therefore is a difficult bias to avoid.103, 104 However, due to small the numbers
present in included studies with no randomization present, unknown confounding biases could
not be controlled.
Two studies7, 18 answered "no" to question 2, regarding similarity in stage of disease. These
studies included patients with varying T-stages with swallowing outcome results combined
together. This further added confounding bias to the studies. This is another common
occurrence in many surgical studies, due to small population numbers present. Both
publications otherwise had sound methodology, and thus were included in the systematic
review.7, 18
Question 7 regarding outcomes of patients who withdrew from the study was typically
answered with "no" or "not applicable". "Not applicable" was answered in studies where no
patients withdrew, and "no" was answered as patients were excluded if they failed to be
evaluated.
25
Table 4. Results of critical appraisal of cohort studies.
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9
Borggreven3 Y Y Y Y Y Y N Y Y
Chien4 Y Y Y Y Y Y N Y Y
Farace5 Y Y Y N Y Y N Y Y
Keiner18 Y N Y N Y Y N/A Y Y
Longo17 Y Y Y N Y Y N/A Y Y
O'Connell6 Y Y Y Y Y Y N/A Y Y
Rieger7 Y N Y Y Y Y N Y Y
Seikaly8 Y Y Y Y Y Y N/A Y Y
% 100 25 100 63 100 100 0 100 100
Y = Yes, N = No, N/A = Not applicable, U/C = Unclear
JBI Critical Appraisal Checklist for Comparable Cohort/Case Control
Q1. Is sample representative of patients in the population as a whole?
Q2. Are the patients at a similar point in the course of their condition/illness?
Q3. Has bias been minimized in relation to selection of cases and of controls?
Q4. Are confounding factors identified and strategies to deal with them stated?
Q5. Are outcomes assessed using objective criteria?
Q6. Was follow up carried over a sufficient time period?
Q7. Were the outcomes of people who withdrew described and included in the analysis?
Q8. Were outcomes measured in a reliable way?
Q9. Was appropriate statistical analysis used?
Case-series Studies:
All patients selected for these studies were consecutive patients treated at a single institution.
Prospective studies with ten patients or less conducted at a single institution were classified
as case-series. Similar to the cohort studies, the same confounding factors were present and
thus question 3 was answered "no". Although sufficient descriptions of the groups were
present, five of the included studies made no comparisons and thus questions 5 was answered
not applicable.102, 105-108 None of the patients excluded from the studies were included in the
analysis, thus question 7 was answered not applicable. Hsiao109 compared swallowing
outcomes between RFFF reconstruction with primary closure, with sufficient descriptions of
both groups. The primary closure group was excluded from the review process as it met
exclusion criteria. Li108 was the only included study not to describe in detail their surgical
technique, thus it is unclear if surgical access was achieved through a mandibulotomy or per-
oral approach.
26
Table 5. Results of critical appraisal of case-series.
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9
Haddock105 Y Y N Y N/A Y N/A Y Y
Hartl102 Y Y N Y N/A Y N/A Y Y
Hsiao109 Y Y N Y Y Y N/A Y Y
Li108 Y Y N Y N/A Y N/A Y Y
Moerman106 Y Y N Y N/A Y N/A Y Y
Shin9 Y Y N Y Y Y N/A Y Y
Winter107 Y Y N Y N/A Y N/A Y Y
% 100 100 0 100 29 100 0 100 100
Y = Yes, N = No, N/A = Not applicable, U/C = Unclear
JBI Critical Appraisal Checklist of Descriptive/Case Series
Q1. Was study based on a random or pseudorandom sample?
Q2. Were the criteria for inclusion in the sample clearly defined?
Q3. Were confounding factors identified and strategies to deal with them stated?
Q4. Were outcomes assessed using objective criteria?
Q5. If comparisons are being made, was there sufficient descriptions of the groups?
Q6. Was follow up carried out over a sufficient time period?
Q7. Were the outcomes of the people who withdrew described and included in the
analysis?
Q8. Were outcomes measured in a reliable way?
Q9. Was appropriate statistical analysis used?
3.3. Description of included studies
Eight cohort studies and seven case series were included in this review. All articles were
published between 2000 and 2013. Three studies were completed in Canada6-8, two in
Taiwan4, 109 and Italy5, 17 and one in United States of America105, Netherlands3, France102,
Germany18, United Kingdom107, South Korea9, China108 and Belgium106.
The age of all patients included ranged between 23 and 87 with mean of 61, with all studies
having similar age range. 79% of all patients included were males, which is typically seen in
all head and neck malignancies110.
Follow up period for studies ranged between 6 and 93 months following curative surgery. The
vast majority of swallowing evaluation occurred within 12 months of treatment in all studies.
Heterogeneity present in the included studies include differing surgical access technique,
stages of malignancy, sub-sites of malignancy and varying and sizes of resection. Due to the
heterogeneity of the studies included in this review, pooled data was deemed unlikely to yield
27
statistically valid results. Thus a narrative summary and discussion was chosen to highlight
the analysis.
Three of the included studies utilized subjective methods to assess swallowing outcomes9, 107,
108, with the remaining 12 studies focusing on objective methods of assessment.3-8, 17, 18, 102, 105,
106, 109 Subjective evaluation included the self-administered MD Anderson Dysphagia Inventory
(MDADI) and University of Washington Quality of Life (UW-QoL).9, 107 Six studies utilized
gastrostomy dependency and seven studies utilized tracheostomy dependency as a measure
of swallowing assessment.4, 6-8, 17, 18, 102, 105, 106 Five studies employed bolus transit time
measured with VFSS in the assessment of swallowing.3, 5, 7, 17, 109 Nine studies reviewed the
presence of aspiration via VFSS or FEES in the evaluation of swallowing.3-8, 18, 102, 105 The
results of the swallowing outcomes are presented below, with a summary of included studies
in Appendix V.
28
Subjective Assessments
Three case-series evaluated swallowing outcomes with the use of subjective questionnaires.9,
107, 108 Shin found postoperative radiotherapy was associated with poorer MDADI scores (Table
6).9 Li and Winter both utilized the UW-QoL to review swallowing outcomes following surgery
with adjuvant therapy (Table 6).107, 108 Furthermore, Li found cancer of the tongue and floor of
mouth had poorer swallowing outcomes than buccal tumors.108 Six patients were excluded
from the Winter study as one patient underwent primary closure, and five patients underwent
supraglottic laryngectomies. All studies found postoperative radiotherapy or chemotherapy
was also associated with more tongue shrinkage and decreased coordinated tongue
movements. Furthermore, subcutaneous fibrosis, mucosal oedema, trismus and xerostomia
secondary to radiotherapy had a cumulative effective on swallowing outcomes.9, 107
Table 6. MDADI Scores
RFFF: Radial forearm free flap; S: Surgery; RT: Radiotherapy
Table 7. UW-QoL Scores
BOT: Base of tongue; RFFF: Radial forearm free flap; RMF: Rectus myocutaneous flap; S: Surgery;
RT: Radiotherapy
Seven cohort studies and two case series reviewed the presence of aspiration as an outcome
of dysphagia (Table 8).3-8, 18, 102, 105 Three studies identified aspiration with the use of flexible
nasoendoscopy.5, 18, 102 The remaining six studies utilized VFSS in the evaluation of
aspiration.3, 4, 6-8, 105 Three of these studies used varying consistencies of food (liquid, pudding,
cookie) with their VFSS, however, found not all patients were able to tolerate all consistencies.
3, 7, 8 Penetration aspiration scale (PAS) was utilized in two studies, where penetration was
Study Site Population Stage Flap Treatment
Regime
Evaluation
Time
(Months)
MDADI
Score
Surgery
only
MDADI
Score
Surgery + RT
Shin9 Oral
tongue
31 T1, T2 RFFF S + RT 21-91 80.5 +/-
10.9
64.77 +/-
16.34
Study Site Population Stage Flap Treatment
Regime
Evaluation
Time
(Months)
UW-QoL
Score
Li108 Oral Tongue,
FOM, Gum,
Buccal
mucosa
51 T1, T2,
T3, T4
ALTF S + CRT 12-84 49
Winter107 BOT 6 III, IV RFFF, RMF S + RT 9-56 63.33
29
defined as a score of 2-5 and aspiration was defined as 6-8.3, 7 Swallowing outcome was
negatively correlated with percentage of oral tongue or BOT resected. Patients treated with
near total glossectomy had greater chances of achieving improved swallowing outcome
compared with total glossectomy.4 There was minimal change in incidence of aspiration at six
and twelve months following curative surgery.3, 7 Nil significant difference in aspiration rates
between flaps utilized, although RFFF was by far the most common. Aspiration detected on
VFSS or FEES lead to gastrostomy or tracheostomy dependency in some patients.4, 6-8, 102
30
Objective Assessments
Aspiration
Table 8. Summary of Aspiration
Study Site Population Stage Free
Flap
Treatment
Regime
Aspiration
@ Preop
Aspiration
@ 6/12
Aspiration
@ 12/12
Borggreven3 Oral tongue,
FOM, BOT,
Tonsil, Soft
palate
54 II, III, IV RFFF S + RT - L-18 (34%) L-14 (25%)
Chien4 Oral tongue,
BOT
29 T3, T4 RFFF,
ALTF
S + CRT - - 9 (31%)
Farace5 Oral cavity 20 T2, T3 ALTF,
RFFF
S - 0 (0%) -
Haddock105 Oral tongue 8 III, IV VRAM S + RT - - 0 (0%)
Hartl102 Oral tongue,
BOT
5 IV RFFF,
LDF,
RMF
S + RT - - 2 (40%)
Keiner18 Oral 49 T2, T3,
T4
RFFF S + RT - - 0 (0%)
Oropharynx 101 T2, T3,
T4
RFFF S + RT - - 0 (0%)
O’Connell6 BOT, Lateral
pharyngeal
wall, Soft
palate
36 III, IV RFFF S+ CRT - - P-1(3%)
Rieger7 BOT, Lateral
pharyngeal
wall, Soft
palate
32 T1, T2,
T3, T3
RFFF S + CRT L-0 (0%)
P-0(0%)
L-5 (21%)
P-4 (17%)
L-4 (21%)
P-1 (19%)
Seikaly8 BOT, Lateral
pharyngeal
wall, Soft
palate
18 III, IV RFFF S + RT - - L-3 (17%)
P-2 (11%)
FOM: Floor of mouth; BOT: Base of tongue; ALTF: Anterolateral thigh flap; RFFF: Radial forearm free
flap; VRAM: Vertical rectus abdominus myocutaneous flap; LDF: Latissiumus dorsi flap; RMF: Rectus
myocutaneous flap; S: Surgery; RT: Radiotherapy; CRT: Chemoradiotherapy; L: Liquid; P: Pudding
Four cohort studies and three case-series reviewed gastrostomy dependency (Table 9).4, 6-8,
102, 105, 107 All patients in included studies had late stage malignancies with reconstructions
utilizing various flaps. Patients requiring gastrostomy feeds at time of evaluation was
secondary to significant aspiration.4, 6-8, 102 Chien found nil significant difference in success of
oral feeding among RFFF and ALTF.4
31
Gastrostomy Tube Dependency
Table 9: Summary of Gastrostomy Dependency
Study Malignancy
Site
Population Stage Flap Treatment
Regime
Evaluation
Time
(Months)
Gastrostomy
Chien4 Oral tongue,
BOT
29 T3, T4 RFFF, ALTF S + CRT 12 3 (10%)
Haddock105 Oral tongue 8 III, IV VRAM S + RT 12 0 (0%)
Hartl102 Oral tongue,
BOT
5 IV RFFF, LDF, RMF S + RT 24 1 (20%)
O’Connell6 BOT, Lateral
pharyngeal
wall, Soft
palate
36 III, IV RFFF S+ RT 12 4 (11%)
Rieger7 BOT, Lateral
pharyngeal
wall, Soft
palate
32 T1, T2, T3, T4 RFFF S + CRT 6 - 12 3 (9%)
Seikaly8 BOT, Lateral
pharyngeal
wall, Soft
palate
18 III, IV RFFF S + RT 6 - 9 1 (6%)
Winter107 BOT 6 III, IV RFFF, RMF S + RT 9 - 56 0 (0%)
BOT: Base of tongue; RFFF: Radial forearm free flap; ALTF: Anterolateral thigh flap; VRAM: Vertical
rectus abdominus myocutaneous flap; LDF: Latissiumus dorsi flap; RMF: Rectus myocutaneous flap;
S: Surgery; RT: Radiotherapy; CRT: Chemoradiotherapy
Five cohort studies and two prospective case-series reviewed tracheostomy dependency as
a swallowing outcome (Table 10). Six of the included studies mentioned routine preoperative
insertion of tracheostomies.4, 6, 7, 17, 105, 106 Five studies found all their patients to be
decannulated prior to their evaluation at least 6 months following curative surgery.6, 7, 17, 105, 106
Two studies had patients requiring tracheostomy at time of evaluation, both who had
resections involving the oropharynx, primarily for pulmonary toileting.4, 18
32
Tracheostomy Dependency
Table 10: Summary of Tracheostomy Dependency
BOT: Base of tongue; RFFF: Radial forearm free flap; ALTF: Anterolateral thigh flap; VRAM: Vertical
rectus abdominus myocutaneous flap; S: Surgery; RT: Radiotherapy; CRT: Chemoradiotherapy
Four cohort studies and one case-series reviewed bolus transit time via VFSS as an evaluation
method of dysphagia (Table 11).3, 5, 7, 17, 109 One study utilized pudding in the evaluation of OTT
and PTT,7 whereas two studies used liquid consistency in their evaluation of OTT and PTT.3,
109 Minimal difference between OTT at six and 12 months following treatment was found.3, 7
Addition of chemotherapy to the regime was associated with increased transit time.7, 109 Farace
measured OTT with nasoendoscopy and varying consistencies of food, and thus transit time
measurement was different other included studies.5
Study Malignancy
Site
Population Stage Flap Treatment
Regime
Evaluation
Time
(Months)
Tracheostomy
Chien4 Oral tongue,
BOT
29 T3, T4 RFFF,
ALTF
S + CRT 12 1 (3%)
Haddock105 Oral tongue 8 III, IV VRAM S 12 0 (0%)
Keiner18 Oral cavity 49 T2,
T3, T4
RFFF S + RT 8-15 0 (0%)
Oropharynx 101 T2,
T3, T4
RFFF S + RT 8-15 1 (2.9%)
Longo17 Oral tongue 13 T3, T4 ALTF S + RT 6-18 0 (0%)
Moerman106 Tonsil, Soft
palate, Lateral
pharyngeal
wall
4 T2, T3 RFFF S+ RT 8-21 0 (0%)
O’Connell6 BOT, Lateral
pharyngeal
wall, Soft
palate
36 III, IV RFFF S + RT 12 0 (0%)
Rieger7 BOT, Lateral
pharyngeal
wall, Soft
palate
32 T1,
T2,
T3, T4
RFFF S + CRT 6 – 12 0 (0%)
33
Oral and pharyngeal transit time
Table 11: Summary of oral and pharyngeal transit time
Study Site Population Stage Flap Treatment
Regime
OT
T @
Pre
op
(s)
OTT
@
6/12
(s)
OTT
@
12/12
(s)
PTT
@
Preo
p (s)
PTT
@
6/12
(s)
PTT
@ 12
/12
(s)
Borggreven3 Oral tongue,
FOM, BOT,
Tonsil, Soft
Palate
54 II, III, IV RFFF S + RT - 0.56
+/-
0.38
0.52
+/-
0.48
- 1.04
+/-
0.41
1.09
+/-
0.48
Farace5 Oral cavity 20 T2, T3 RFFF
ALTF
Unclear - <10 - - - -
Hsiao109 Oral tongue 4 T2, T3 RFFF S + CRT - - 1.21 - - -
Longo17 Oral tongue 13 T3, T4 ALTF S + RT - - 0.79 - - -
Rieger7 BOT, Lateral
pharyngeal
wall, Soft
palate
32 T1, T2,
T3, T4
RFFF S + CRT 0.8
0
+/-
1.0
1
1.16
+/-
1.43
1.24
+/-
1.20
0.94
+/-
0.47
1.27
+/-
1.00
1.96
+/-
2.14
FOM: Floor of mouth; BOT: Base of tongue; RFFF: Radial forearm free flap; ALTF: Anterolateral thigh
flap; S: Surgery; RT: Radiotherapy; CRT: Chemoradiotherapy; OT: Oral transit time; PTT: Pharyngeal
transit time
None of the studies included in this review evaluated swallowing outcomes utilizing
manometry or functional oral intake scale.
Surgery alone Vs. Surgery and Adjuvant Therapy
Shin was the only study to directly compare the MDADI scores of patients treated with surgery
alone against surgery with adjuvant therapy. They found postoperative RT to be associated
with poorer MDADI scores.9 They inferred tongue shrinkage following radiotherapy resulted in
decreased coordinated tongue movements, thus impairing swallowing efficiency. The studies
published by Winter and Li consisted of patients treated predominately with surgery and
adjuvant therapy.107, 108 Although there was no direct comparison regarding the effects of
postoperative RT, they both correlated postoperative RT with lower UW-QoL scores. Farace
was the only study to include patients treated with primary surgery alone, and found no
patients suffered from with aspiration at six months (Table 8).5 As they employed
nasoendoscopy for the measurement of OTT, results were not comparable to the other
included studies. Although the majority of included studies did not directly investigate the
effects of postoperative RT, poorer swallowing outcomes were inferred to be secondary to RT.
18, 102
34
Radial Forearm Free Flap Vs. Anterolateral Thig Flap
Radial forearm free flaps were utilized in 12 of the included studies.3-8, 18, 102, 106, 109 Chien found
improved muscular function with the thin pliable RFFF due to its smaller bulk compared with
the ALTF. However, overall they found no significant difference between the various flaps4
Five of the included studies solely utilized the RFFF and found its thin pliable attributes allow
it to integrate well with the oral cavity and oropharynx, thus leading to improved swallowing
outcomes. 3, 7, 8, 18, 106 Farace compared the RFFF and ALTF in the reconstruction of oral
defects and found no significant differences regarding functional outcomes.5 They suggested
the use of ALTF for intraoral reconstructions due to decreased donor site morbidity. Longo
also favored the ALTF due to lower donor site morbidity with reliable revascularization without
sacrificing the radial artery.17 They found the only drawback of the ALTF to be the large amount
of bulk potentially affecting movement of the neotongue, however, thinning was achievable
with careful dissection of the suprafascial plane.
Oral Cavity Vs. Oropharynx
Oropharyngeal resections lead to worse swallowing outcomes compared with oral cavity.
Resections of the soft palate in combination with the BOT had the most swallowing
complications including penetration and aspiration. 3 Resections of the soft palate, tongue
base, pharyngeal walls typically required reconstruction to decrease risk of strictures. 18
Tongue and FOM had poorer outcomes compared to buccal region. 108 Tracheostomy
dependency occurred in two patients in the included studies, of which both underwent
resections involving their oropharynx (Table 10).4, 18
35
Chapter 4: Discussion
4.1. Overview of findings
Treatment modalities for oral and oropharyngeal squamous cell carcinomas have improved
oncological outcomes over recent years, with goals now aimed at improving functional
outcomes, such as swallowing. Numerous studies have investigated swallowing outcomes
following treatment of head and neck cancers. However, due to the complexity and multitude
of processes involved in deglutition, there is currently no standardized approach to the
assessment of swallowing. Postoperative deglutition function is a vital aspect in a patient's
quality of life, and thus a thorough and systematic approach must be applied in the evaluation
of these patients.
This systematic review sought to retrieve and synthesize the best available evidence on the
swallowing function of patients with oral or oropharyngeal squamous cell carcinoma treated
with primary surgery with primary free flap reconstruction with or without adjuvant therapy. A
total of eight cohort studies3-8, 17, 18 and seven case-series9, 102, 105-109 met the inclusion criteria
and methodological quality, were included in this review. There was a large variation in
methodological design and reporting of results in the included studies. Despite the lack of high
quality randomized data currently available, the included studies are a representative sample
of the current available literature. Large amounts of heterogeneity existed between these
published studies, thus causing difficulty in pooling of results for meta-analysis. The studies
included in this review evaluated patients with squamous cell carcinoma of varying sub-sites
of the oral cavity and oropharynx. The swallowing outcomes of varying sub-sites were typically
combined together due to the small population numbers available. This lead to decreased
validity in studies as differing sub-sites contributed to deglutition more than others. The
included studies also consisted of patients with varying stages of disease, ranging from T1 to
T4 and stage II to IV. This factor further added to the confounding biases commonly present
in surgical studies, as it is well established patients requiring larger resections will have poorer
swallowing outcomes.7, 111 In addition, differing surgical access techniques such as
mandibulotomies and peroral access have vastly different swallowing outcomes. Invasive
mandibulotomies involve disruption of the oral and pharyngeal anatomy and physiology,
typically leading to poorer outcomes. Lastly, preferences between surgeons and institutions
played a large role in functional outcomes. Therefore, findings in this study were presented in
narrative form due to the heterogeneity present in this review.
36
The included studies in this review have associated a dose-dependent relationship between
postoperative radiotherapy and worsening swallowing function. Shin was the only article to
specifically review this relationship, and found a significant decrease in MDADI score following
radiotherapy.9 Shin attributed this worsening swallowing function to excessive reconstructed
tissue shrinkage secondary to RT.9 Furthermore, two studies found no improvement in
swallowing function between six and twelve months following surgery and adjuvant RT.3, 7
Their findings were similar to the results from Pauloski, who also found minimal improvement
in swallowing function after RT.112 These findings suggest decreased healing ability in
combination with fibrosis, causing impaired swallowing function at six months following RT. In
addition, late complications of RT consisting of subcutaneous fibrosis, trismus and salivary
gland dysfunction all have a cumulative and detrimental impact on swallowing function.
Although this study did not focus specifically on these complications, the presence of these
effects is evidenced by prolonged gastrostomy dependency and increased transit times. The
findings from this review are further supported by other published reviews demonstrating
improved swallowing outcomes with surgery alone compared with surgery and adjuvant
CRT.46, 48 Moncrieff et al found evidence to support the use of primary surgery alone for the
treatment of T1 and T2 oropharyngeal SCC, thus avoiding the side effects of adjuvant RT.38
They recommended postoperative RT for local control of high-risk primaries or regional control
of bulky cervical metastases. Despite the great debate regarding optimal treatment of oral and
oropharyngeal SCC, the above findings demonstrate a potential for primary surgery-alone for
a select group of patients, thus sparing the effects of RT for these patients. Evidence from this
systematic review support the development of a protocol for the identification of patients at
high and low risk of developing post-treatment swallowing dysfunction. Furthermore, these
stratified patients should be monitored closely with a standardized swallowing protocol. This
proposed protocol will lead to improved understanding of dysphagia and better counseling for
patients preoperatively.
Currently published literature show promising results encouraging the use of swallowing
exercises to decrease the incidence of post-treatment dysphagia.113, 114 115-117 Scherpenhuizen
found statistically significant increased interincisal opening in patients who utilized jaw-
mobilizing device compared with no exercise.113 Furthermore, two randomized control trials
have found swallowing exercise programs associated with superior muscle maintenance and
functional swallowing ability.114, 115 MRI studies in the Carnaby-Mann study demonstrated
maintenance of muscle characteristics following swallowing exercises.115 They proposed the
“pharyngocise” protocol may be associated with decreased inflammatory changes following
treatment with CRT. Furthermore, Carroll and Kulbersh found pre-treatment swallowing
exercises to be correlated with improved swallowing function post-CRT.116, 117 These results
37
show promising results for the use of swallowing exercises pre- and during treatment for
patients undergoing CRT. These results, however, need to be validated with further research.
Microvascular free flap reconstructions have been employed in the reconstruction of surgical
defects as they allow for wider resection margins and are able to improve swallowing
outcomes by restoring tissue bulk.18, 118, 119 Hsiao found primary closure of the defect resulted
in a small mobile tongue which lacked volume and lead to ineffective deglutition.119 Flap
selection is dependent on the size and location of the defect, however, donor site morbidity
must be taken into account. Donor sites are associated with the potential of increased pain,
delayed wound healing and unsightly scars. All these factors need to be taken into account
prior to surgical resection and reconstruction. The majority of the cases included in this study
utilized RFFF, however, a small number of studies also employed the ALTF, RMF, VRAM and
LDF in their reconstructions. Farace and Longo suggested the use of the ALTF for
reconstruction, due to lower rates of donor site morbidity.5, 17 These findings are supported by
published literature favoring the use of ALTF due to its versatility, presence of abundant
perforating vessels and bulk for head and neck reconstructions.120 Systematic review
published by Lam, similarly found difficulty in concluding the ideal free flap for optimal
functional outcomes.74 Due to the heterogeneity involved in the studies, there is no clear
consensus on the efficacy of RFFF over ALTF for the reconstruction of oral or oropharyngeal
defects. Graft choice is largely dependent on the defect size as well as surgeon preference.
Compared with primary closure, microvascular reconstruction has been demonstrated to
improve deglutition.119 Hsiao was able to demonstrate the additional bulk was necessary to
close the dead space in the oral cavity, and allow for sufficient tongue to soft palate
contraction.109 Keiner recommended primary closure only for T1 tumors, as opposition of
adjacent mucosa in larger resections is not always possible.18 They also found scar tissue
formation, particularly in the oropharynx, lead to narrowing of the digestive tract. McConnel
found small resections of the oral or base of tongue demonstrated nil improvement in
swallowing efficiency between primary closure and flap repair.121 In larger resections, free
flaps have demonstrated versatility in being able to repair surgical defects without tethering
the tongue to surrounding structures.122, 123 Despite advances in microvascular reconstruction,
some studies demonstrated pharyngeal bolus transit time to be increased with no recovery to
preoperative function.3, 124 Lam found when tumor resection was limited to either oral tongue
or BOT, good functional outcome can be obtained through immediate free flap
reconstruction.74
38
Due to the complexity of swallowing and lack of standardization in its assessment, this
systematic review chose a combination of validated objective and subjective assessments to
evaluate swallowing function. Aspiration was noted to be a commonly utilized measure of
dysphagia among studies, with its detection via VFSS or nasoendoscopy. Penetration-
aspiration scale is a validated tool in quantifying the severity of penetration or aspiration, which
was only utilized in two studies.3, 7 The rate of aspiration was variable among studies, as
differing consistencies of food boluses were employed. The presence of aspiration is an
important factor to consider with regards to dysphagia, as it has the potential to lead to life-
threatening lower respiratory tract infections. The presence of persistent aspiration and
dysphagia results in the insertion of gastrostomy tubes and tracheostomies in some patients.
However, the presence of pneumonia was not utilized as an outcome of dysphagia as there
is great difficulty in ascertaining if the infection was secondary to aspiration or another cause.
Gastrostomy tubes were employed when there was a persistence of aspiration, severe
odynophagia, dysphagia or unable to maintain adequate nutrition. The included studies
showed a low rate of gastrostomy dependency, with removal typically prior to 12 months
following surgery. Other published systematic reviews similarly found variable rates of
gastrostomy dependency, ranging up to 75%.75 Haddock et al105 was the only study to
prophylactically insert gastrostomy tubes prior to treatment. Prophylactic gastrostomy tube
placement is practiced in some institutions with the goal of maintaining nutrition, avoiding
interruptions in treatment and improving tolerance and response to CRT.125-127 However,
studies have associated early gastrostomy tube insertion to be associated with long term
dysphagia and decreased quality of life, likely secondary to disuse muscle atrophy and
fibrosis.43, 128 Swallowing exercises have been employed in the treatment regime to reduce the
effects of CRT, with promising results. 114, 115 The presence of gastrostomy tubes as a marker
for dysphagia may be influenced by other factors, such as anxiety or lack of education involved
with the use of gastrostomy tubes.129 Therefore, it is important to utilize gastrostomy
dependency in conjunction with other assessment tools.
Tracheostomy dependency is not a commonly utilized measure of dysphagia in current
literature. It, however, plays a large role in swallowing function due to its potential to distort
pharyngeal anatomy and physiology when in situ. Tracheostomies are commonly conducted
in head and neck cancer cases involving large resections, as it allows for a definitive airway.
This was mentioned in six of the included studies.4, 6, 7, 17, 105, 106 Tracheostomy dependency
was low and occurred only in patients who underwent oropharyngeal resections, due to
recurrent aspiration or need for frequent pulmonary toileting. Thus tracheostomy dependency
is not only a marker for dysphagia, but is also a source of dysphagia. Despite the majority of
39
included studies in this systematic review performing mandibulotomies, the tracheostomy
dependency rates were similar to rates following transoral robotic surgery.48
Bolus transit time is an effective and versatile method of evaluating swallowing function. The
included studies measured a combination of oral, oropharyngeal and pharyngeal transit times.
Despite the lack of standardization in the measurement of bolus transit time, all studies based
their procedure on the study published by Lazarus and colleagues.130 The consistency used
varied between liquid and pudding in included studies, thus causing great difficulty in drawing
conclusions from the results. Due to its use in conjunction the VFSS, the movement of
anatomical structures can be assessed during the same procedure. However, due to the vastly
differing measures of movement in pharyngeal structures available, this was not used in the
review.
Manometry is a gold standard for the assessment of esophageal motility disorders, however,
is technically demanding and requires experienced and specialized staff. Manometry is
typically used in the investigation of dysphagia, however, is only performed when diagnosis
has not been achieved with other forms of investigations. The complexity of this procedure
causes difficulty in access to this form of investigation, thus it is the likely reason none of the
included studies utilized manometry as an evaluation method of swallowing function.
However, studies have demonstrated the important role of impedance manometry as an
alternative non-radiological method in the assessment of oropharyngeal swallowing
disorders.131
Subjective questionnaires are integral to the evaluation of dysphagia in patients following
cancer therapy. It provides clinicians with important information regarding the patient's
perception of their physical and emotional state. Therefore, it is extremely important to
combine both objective and subjective methods for a more holistic management regime. The
MD Anderson Dysphagia Inventory (MDADI) and University Washington Quality of Life
Questionnaire (UW-QoL) have both been validated for use in head and neck cancer patients.
The included studies that utilized subjective questionnaires showed similar scores among the
patients treated. Interestingly, Kendall and colleagues demonstrated a lack of correlation in
quality of life and physiological functioning.132 It is important to consider the questionnaires
measure the patient's emotional response to their disease and different aspects of their life.
This association between objective and subjective evaluations require further research.
Swallowing evaluation is an integral component in the management of patients following
treatment of head and neck malignancy. Due to the complexity of dysphagia, there is not a
40
standardized protocol for post-treatment swallowing evaluation. A wide range of assessment
tools is currently available to clinicians, ranging from subjective questionnaires to bedside
nasoendoscopy to videofluoroscopy in the radiology suites. Despite these advances in
assessments available, there is a lack of published literature investigating swallowing in a
standardized manner. There is a need for a well-designed prospective longitudinal cohort
study to assist furthering our knowledge on post-treatment swallowing outcomes. VFSS and
FEES should be utilized routinely in the evaluation of dysphagia, as they are able to provide
large amounts of information regarding deglutition. Detection of aspiration is paramount in
decreasing rates of aspiration pneumonia, thus improving quality of life. Ideally, the evaluation
of aspiration with the use of the validated penetration-aspiration scale allows quantitative
grading. Due to the late toxicities following the CRT, more studies are required to evaluate
long term swallowing outcomes greater than one to two years. Studies should aim to include
both objective investigations with subjective questionnaires for a more holistic approach. A
standardized protocol for the measurement of transit time and movement of pharyngeal
structures should be developed and validated, thus allowing for in-depth investigation of
changes following treatment with CRT.
4.2. Limitations to the study
The search strategy for this systematic review was limited to studies published in English.
Therefore, studies published in languages other than English may have added to the findings
in this review. Furthermore, there was a lack of high quality studies due to the nature of the
topic. Improvements in methodology and reporting of data is required for future studies.
Primary studies should include clearly documented inclusion and exclusion criteria with
surgical resection and reconstruction techniques clearly described. Patients with malignancies
of similar stage should be grouped together. Additionally, results from swallowing evaluations
should be clearly documented.
4.3. Implications for practice
This review included studies of varying methodological quality by the critical appraisal process.
Due to the nature of this topic, high quality evidence is currently limited. Interpretation of the
findings provide credible evidence useful in clinical practice with the potential to produce useful
strategies in identifying patients at high risk of developing dysphagia post-treatment, and in
turn have appropriate swallowing evaluations and follow up. A number of recommendations
for practice have been developed based upon the results of this review which have been
graded using the JBI approach. Grades of Recommendation are used to assist healthcare
professionals when implementing evidence into practice.
41
The JBI Levels of Evidence and Grades of Recommendations is based on the JBI "FAME
Model" of feasibility, appropriateness, meaningfulness and effectiveness.133 Grade A
recommendations are considered "strong" recommendations, whereas, Grade B
recommendations, are considered "weak" recommendations for a health management
strategy. Due to the quality of included studies and current available literature, the
recommendations from this review are Grade B.
Based upon the findings from this systematic review, it can be recommended that patients
receiving treatment for their oral and oropharyngeal squamous cell carcinoma are identified
early by using a validated screening protocol that stratifies patients into low and high risk of
developing post-treatment dysphagia. A draft protocol for dysphagia risk stratification for the
assessment of patients diagnosed with oral and oropharyngeal squamous cell carcinomas
was developed (Appendix VII). Such a protocol will also be able to be used to facilitate
counselling for patients with regard to their likelihood of experiencing post-treatment
dysphagia. The proposed protocol contains the following recommendations for practice:
Low risk patients with early stage malignancy (T1 and T2) with no evidence of regional or
distant metastases, may benefit with less dysphagia from surgery-alone without
radiotherapy to the primary tumor. (Grade B)
Larger resections involving combinations of the BOT, oral tongue and soft palate with the
addition of RT following resection would be deemed higher risk to be associated with long-
term dysphagia. (Grade B)
Preoperatively, all patients require evaluation with FEES and subjective questionnaires.
(Grade B)
Postoperatively, patients should be closely monitored with quality of life questionnaires
and routine FEES to evaluate for aspiration, with use the aspiration-penetration scale.
(grade B)
Patients deemed higher risk will require closer monitoring with the use of VFSS pre- and
postoperatively. (Grade B)
4.4. Implications for research
There was a lack of high level evidence in the area of swallowing outcomes following primary
surgery and primary free flap reconstruction. Due to ethical concerns, no high quality
randomized control trials have been published. The only available literature on this topic are
cohort and case-series studies. These studies require clearly defined inclusion and exclusion
criteria with detailed descriptions of surgical techniques and adjuvant therapies involved.
42
Furthermore, different stages and sub-sites of cancer must ideally be stratified separately to
decrease confounding factors. All these elements must be addressed to produce a high quality
study. A standardized protocol of swallowing function is required, consisting of both objective
and subjective assessments. Subjective assessments such as the MDADI and UW-QoL are
both validated questionnaires that should be routinely utilized. These subjective findings
should be utilized with findings from objective investigations for a holistic approach. The
reporting of these outcomes must be standardized and detailed for it to be used in a meta-
analysis. The use of the dysphagia risk stratification protocol is recommended to be used in
clinical practice. Patients stratified into the low and high risk groups should be followed
prospectively, monitored with both objective and subjective swallowing evaluations. The long
term outcomes of these patients should be documented clearly, and will assist in validating
the effectiveness of this protocol. A prospective multi-centered approach would be a preferred
method of performing a high quality study.
4.5. Conclusion
Swallowing function is a fundamental component in the management of patients following
treatment of head and neck malignancy. Due to the intricacy of swallowing, there is yet to be
a standardized protocol for post-treatment dysphagia evaluation. A vast array of objective and
subjective assessment tools are currently available, however, there is still a lack of published
literature investigating swallowing in a standardized manner.
This systematic review has retrieved and collated the best available evidence in the literature
on swallowing outcomes following primary surgical resection with primary free flap
reconstruction. Results have found that postoperative radiotherapy has been demonstrated to
adversely affect swallowing outcomes. Furthermore, there is currently no consensus regarding
swallowing outcomes between the use of radial forearm free flaps and anterolateral thigh flaps,
both appear to be efficacious. Lastly, primary free flap reconstruction has been demonstrated
to have improved swallowing outcomes compared with primary closure.
There is a need for a well-designed prospective longitudinal cohort study to assist furthering
our knowledge on post-treatment swallowing outcomes. Furthermore, long term studies are
required to review late toxicities following CRT. Studies should aim to combine both objective
investigations with subjective questionnaires for a more holistic approach. A standardized
protocol for identifying low and high risk patients with corresponding swallowing evaluations
has been proposed.
43
References
1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009;151(4):264-9.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, DM P. GLOBOCAN 2008 v2, cancer incidence and mortality worldwide: IARC cancerbase No. 10 Lyon (France): International Agency for Research on Cancer 2010.
3. Borggreven PA, Verdonck-De Leeuw IM, Rinkel RN, Langendijk JA, Roos JC, David EFL, et al. Swallowing after major surgery of the oral cavity or oropharynx: A prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction. Head Neck. 2007;29(7):638-47.
4. Chien CY, Su CY, Hwang CF, Chuang HC, Jeng SF, Chen YC. Ablation of advanced tongue or base of tongue cancer and reconstruction with free flap: functional outcomes. Eur J Surg Oncol. 2006;32(3):353-7.
5. Farace F, Fois VE, Manconi A, Puddu A, Stomeo F, Tullio A, et al. Free anterolateral thigh flap versus free forearm flap: Functional results in oral reconstruction. J Plast Reconstr Aesthet Surg. 2007;60(6):583-7.
6. O'Connell DA, Rieger J, Harris JR, Dziegielewski P, Zalmanowitz J, Sytsanko A, et al. Swallowing function in patients with base of tongue cancers treated with primary surgery and reconstructed with a modified radial forearm free flap. Arch Otolaryngol Head Neck Surg. 2008;134(8):857-64.
7. Rieger JM, Zalmanowitz JG, Li SY, Sytsanko A, Harris J, Williams D, et al. Functional outcomes after surgical reconstruction of the base of tongue using the radial forearm free flap in patients with oropharyngeal carcinoma. Head Neck. 2007;29(11):1024-32.
8. Seikaly H, Rieger J, Wolfaardt J, Moysa G, Harris J, Jha N. Functional outcomes after primary oropharyngeal cancer resection and reconstruction with the radial forearm free flap. Laryngoscope. 2003;113(5):897-904.
9. Shin YS, Kim WS, Koh YW, Hong HJ, Lee SY, Choi EC. Radiotherapy deteriorates post-operative functional outcome after partial glossectomy with free flap reconstruction. Oral Oncol. 2011;47:S31-S2.
10. Huber MA, Tantiwongkosi B. Oral and oropharyngeal cancer. Med Clin North Am. 2014;98(6):1299-321.
11. Hashibe M, Sturgis EM. Epidemiology of oral-cavity and oropharyngeal carcinomas: controlling a tobacco epidemic while a human papillomavirus epidemic emerges. Otolaryngol Clin North Am. 2013;46(4):507-20.
12. Gillison ML. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008;43(4 Suppl):S52-60.
13. Amano O, Mizobe K, Bando Y, Sakiyama K. Anatomy and Histology of Rodent and Human Major Salivary Glands: —Overview of the Japan Salivary Gland Society-Sponsored Workshop—. Acta Histochemica et Cytochemica. 2012;45(5):241-50.
14. Holmberg KV, Hoffman MP. Anatomy, biogenesis, and regeneration of salivary glands. Monogr Oral Sci. 2014;24:1-13.
15. Drake RL, Vogl AW, Mitchell AWM, H. G. Gray's anatomy for students. Philadelphia, PA: Churchill Livingstone; 2010.
16. Matsuo K, Palmer JB. Anatomy and physiology of feeding and swallowing: normal and abnormal. Phys Med Rehabil Clin N Am. 2008;19(4):691-707, vii.
17. Longo B, Pagnoni M, Ferri G, Morello R, Santanelli F. The mushroom-shaped anterolateral thigh perforator flap for subtotal tongue reconstruction. Plast Reconstr Surg. 2013;132(3):656-65.
18. Keiner S, Bootz F, Flisek J, Fuchs M. Reconstructive surgery after tumor resection in the oral cavity and oropharynx. Onkologie. 2000;23(3):240-4.
44
19. McConnel FM, Pauloski BR, Logemann JA, Rademaker AW, Colangelo L, Shedd D, et al. Functional results of primary closure vs flaps in oropharyngeal reconstruction: a prospective study of speech and swallowing. Arch Otolaryngol Head Neck Surg. 1998;124(6):625-30.
20. Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer. 2002;94(4):1131-41.
21. Pauloski BR, Logemann JA, Fox JC, Colangelo LA. Biomechanical analysis of the pharyngeal swallow in postsurgical patients with anterior tongue and floor of mouth resection and distal flap reconstruction. J Speech Hear Res. 1995;38(1):110-23.
22. Gaziano JE. Evaluation and management of oropharyngeal Dysphagia in head and neck cancer. Cancer Control. 2002;9(5):400-9.
23. Naidu MUR, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy-Induced and/or Radiation Therapy-Induced Oral Mucositis—Complicating the Treatment of Cancer. Neoplasia (New York, NY). 2004;6(5):423-31.
24. Arcuri MR, Schneider RL. The physiological effects of radiotherapy on oral tissue. J Prosthodont. 1992;1(1):37-41.
25. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199-212.
26. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039-60.
27. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796-807.
28. Dysphagia Section OCSGMAoSCiCISoOO, Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, et al. Swallowing dysfunction in cancer patients. Support Care Cancer. 2012;20(3):433-43.
29. Lazarus C, Husaini H, Jacobson A, Mojica J, Anand S, Urken M. Tongue strength, functional outcomes and quality of life after oral cancer surgery. Dysphagia. 2012;27(4):602.
30. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT, et al. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010;18(8):1033-8.
31. Nagarajan K. Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment. Med Oral Patol Oral Cir Bucal. 2015;20(3):e273-e7.
32. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 7th ed. Sobin LH, Gospodarowicz MK, Wittekind C, editors. Oxford: Wiley-Blackwell 2009. 336 p.
33. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-4.
34. Webber C, Gospodarowicz M, Sobin LH, Wittekind C, Greene FL, Mason MD, et al. Improving the TNM classification: findings from a 10-year continuous literature review. Int J Cancer. 2014;135(2):371-8.
35. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
36. Weinstein GS, O'Malley BW, Jr., Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136(11):1079-85.
37. Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin. 2005;55(4):242-58; quiz 61-2, 64.
45
38. Moncrieff M, Sandilla J, Clark J, Clifford A, Shannon K, Gao K, et al. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Laryngoscope. 2009;119(2):307-11.
39. Givens DJ, Karnell LH, Gupta AK, Clamon GH, Pagedar NA, Chang KE, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2009;135(12):1209-17.
40. Moose BD, Kelly MD, Levine PA, Constable WC, Cantrell RW, Larner JM. Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil. Head Neck. 1995;17(4):334-8.
41. Gourin CG, Johnson JT. A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2009;119(11):2124-34.
42. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(4):941-7.
43. Gillespie MB, Brodsky MB, Day TA LF, B. M-H. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope. 2004;114(8):1362-7.
44. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-52.
45. Frowen JJ, Perry AR. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck. 2006;28(10):932-44.
46. de Almeida JR, Byrd JK, Wu R, Stucken CL, Duvvuri U, Goldstein DP, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096-102.
47. Duek I, Billan S, Amit M, Gil Z. Transoral Robotic Surgery in the HPV Era. Rambam Maimonides Med J. 2014;5(2):e0010.
48. Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272(2):463-71.
49. Chim H, Salgado CJ, Seselgyte R, Wei F-C, Mardini S. Principles of Head and Neck Reconstruction: An Algorithm to Guide Flap Selection. Semin Plast Surg. 2010;24(2):148-54.
50. Hanasono MM. Reconstructive Surgery for Head and Neck Cancer Patients. Advances in Medicine. 2014;2014:795483.
51. Brown JS, Zuydam AC, Jones DC, Rogers SN, Vaughan ED. Functional outcome in soft palate reconstruction using a radial forearm free flap in conjunction with a superiorly based pharyngeal flap. Head Neck. 1997;19(6):524-34.
52. Urken ML, Buchbinder D, Costantino PD, Sinha U, Okay D, Lawson W, et al. Oromandibular reconstruction using microvascular composite flaps: report of 210 cases. Arch Otolaryngol Head Neck Surg. 1998;124(1):46-55.
53. Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MW, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer. 2012;118(23):5793-9.
54. Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006;35(4):337-42.
55. Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, Leemans CR, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009;90(2):189-95.
56. Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope. 2008;118(4):635-9.
57. Lawson JD, Otto K, Chen A, Shin DM, Davis L, Johnstone PA. Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head Neck. 2008;30(3):327-35.
46
58. de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2006;64(2):363-73.
59. Suiter DM, McCullough GH, Powell PW. Effects of cuff deflation and one-way tracheostomy speaking valve placement on swallow physiology. Dysphagia. 2003;18(4):284-92.
60. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2011;137(11):1112-6.
61. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119(11):2156-64.
62. Payakachat N, Ounpraseuth S, Suen JY. Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. Head Neck. 2013;35(6):819-25.
63. Kelly AM, Drinnan MJ, Leslie P. Assessing penetration and aspiration: how do videofluoroscopy and fiberoptic endoscopic evaluation of swallowing compare? Laryngoscope. 2007;117(10):1723-7.
64. Omari T, Tack J, Rommel N. Impedance as an adjunct to manometric testing to investigate symptoms of dysphagia: What it has failed to do and what it may tell us in the future. United European Gastroenterol J. 2014;2(5):355-66.
65. Omari TI, Dejaeger E, Van Beckevoort D, Goeleven A, De Cock P, Hoffman I, et al. A novel method for the nonradiological assessment of ineffective swallowing. Am J Gastroenterol. 2011;106(10):1796-802.
66. Martin-Harris B, Jones B. The Videofluorographic Swallowing Study. Phys Med Rehabil Clin N Am. 2008;19(4):769-85.
67. Nacci A, Ursino F, La Vela R, Matteucci F, Mallardi V, Fattori B. Fiberoptic endoscopic evaluation of swallowing (FEES): proposal for informed consent. Acta Otorhinolaryngol Ital. 2008;28(4):206-11.
68. Bhatia SJ, Shah C. How to Perform and Interpret Upper Esophageal Sphincter Manometry. J Neurogastroenterol Motil. 2013;19(1):99-103.
69. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870-6.
70. McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia. 2000;15(3):115-21.
71. McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia. 2000;15(3):122-33.
72. McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17(2):97-114.
73. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86(8):1516-20.
74. Lam L, Samman N. Speech and swallowing following tongue cancer surgery and free flap reconstruction--a systematic review. Oral Oncol. 2013;49(6):507-24.
75. Dziegielewski PT, Ho ML, Rieger J, Singh P, Langille M, Harris JR, et al. Total glossectomy with laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic review of the literature. Laryngoscope. 2013;123(1):140-5.
47
76. Kao SS, Ooi EH, Peters MDJ. Swallowing outcomes following primary surgical resection and primary free flap reconstruction for oral and oropharyngeal squamous cell carcinomas: a systematic review protocol. JBI Database of System Rev Implement Rep. 2015;13(8):120-34.
77. Burns PB, Rohrich RJ, Chung KC. The Levels of Evidence and their role in Evidence-Based Medicine. Plast Reconstr Surg. 2011;128(1):305-10.
78. Shadish W, Cook T, Campbell T. Experimental and quasi-experimental designs for generalized causal inference. Boston Houghton Mifflin Company 2001.
79. Pearson A, Wiechula R, Court A, Lockwood C. The JBI model of evidence-based healthcare. International journal of evidence-based healthcare. 2005;3(8):207-15.
80. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312(7023):71-2.
81. Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA. 2002;287(21):2831-4.
82. Akobeng AK. Understanding systematic reviews and meta-analysis. Arch Dis Child. 2005;90(8):845-8.
83. The Joanna Briggs Institute. Joanna Briggs Institute Reviewers' Manual: 2014 edition. Adelaide, Australia The Joanna Briggs Institute 2014.
84. Greenhalgh T. How to read a paper. Statistics for the non-statistician. I: Different types of data need different statistical tests. BMJ. 1997;315(7104):364-6.
85. Higgs J, Titchen A. Research and knowledge. Physiotherapy. 1998;84(2):72-80. 86. Greenhalgh T. How to read a paper. Statistics for the non-statistician. II: "Significant"
relations and their pitfalls. BMJ. 1997;315(7105):422-5. 87. Green S, Higgins JPT. Preparing a Cochrane Review. Cochrane Handbook for
Systematic Reviews of Interventions: John Wiley & Sons, Ltd; 2008. p. 11-30. 88. Eysenbach G. Peer Review and Publication of Research Protocols and Proposals: A
Role for Open Access Journals. J Med Internet Res. 2004;6(3):e37. 89. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet.
2002;359(9307):696-700. 90. Harris MR. The librarian's roles in the systematic review process: a case study. J Med
Libr Assoc. 2005;93(1):81-7. 91. Uman LS. Systematic Reviews and Meta-Analyses. Journal of the Canadian Academy
of Child and Adolescent Psychiatry. 2011;20(1):57-9. 92. Yoshii A, Plaut DA, McGraw KA, Anderson MJ, Wellik KE. Analysis of the reporting of
search strategies in Cochrane systematic reviews. Journal of the Medical Library Association : JMLA. 2009;97(1):21-9.
93. Cook DJ, Mulrow CD, Haynes RB. Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions. Ann Intern Med. 1997;126(5):376-80.
94. Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: A retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound. Clinical Otolaryngology. 2012;37(3):197-206.
95. Pearson A, Field J, Jordan Z. Evidence Synthesis: The Systematic Review. Evidence-Based Clinical Practice in Nursing and Health Care: Blackwell Publishing Ltd.; 2009. p. 52-71.
96. Katrak P, Bialocerkowski AE, Massy-Westropp N, Kumar S, Grimmer KA. A systematic review of the content of critical appraisal tools. BMC Med Res Methodol. 2004;4:22.
97. Koch WM. Head and neck surgery in the era of organ preservation therapy. Seminars in oncology. 2000;27(4):5-12.
98. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ : British Medical Journal. 2003;327(7414):557-60.
99. Bernier L, Archambault J, Vigneault E, Fortin A. Regional outcome in N2-N3 patients with head and neck carcinoma in function of FDG PET/CT results. International Journal of Radiation Oncology Biology Physics. 2013;87(2):S441.
48
100. Pierre CS, Dassonville O, Chamorey E, Poissonnet G, Riss JC, Ettaiche M, et al. Long-term functional outcomes and quality of life after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer. Acta Otolaryngol. 2014;134(10):1086-93.
101. Pourhoseingholi MA, Baghestani AR, Vahedi M. How to control confounding effects by statistical analysis. Gastroenterology and Hepatology From Bed to Bench. 2012;5(2):79-83.
102. Hartl DM, Dauchy S, Escande C, Bretagne E, Janot F, Kolb F. Quality of life after free-flap tongue reconstruction. J Laryngol Otol. 2009;123(5):550-4.
103. Brown MB. Control groups appropriate for surgical interventions: ethical and practical issues. Gastroenterology. 2004;126, Supplement 1:S164-S8.
104. Walter CJ, Dumville JC, Hewitt CE, Moore KC, Torgerson DJ, Drew PJ, et al. The quality of trials in operative surgery. Ann Surg. 2007;246(6):1104-9.
105. Haddock NT, DeLacure MD, Saadeh PB. Functional reconstruction of glossectomy defects: the vertical rectus abdominus myocutaneous neotongue. J Reconstr Microsurg. 2008;24(5):343-50.
106. Moerman M, Vermeersch H, Van Lierde K, Fahimi H, Van Cauwenberge P. Refinement of the free radial forearm flap reconstructive technique after resection of large oropharyngeal malignancies with excellent functional results. Head Neck. 2003;25(9):772-7.
107. Winter SCA, Cassell O, Corbridge RJ, Goodacre T, Cox GJ. Quality of life following resection, free flap reconstruction and postoperative external beam radiotherapy for squamous cell carcinoma of the base of tongue. Clin Otolaryngol Allied Sci. 2004;29(3):274-8.
108. Li W, Yang Y, Xu Z, Liu F, Cheng Y, Xu L, et al. Assessment of quality of life of patients with oral cavity cancer who have had defects reconstructed with free anterolateral thigh perforator flaps. Br J Oral Maxillofac Surg. 2013;51(6):497-501.
109. Hsiao HT, Leu YS, Chang SH, Lee JT. Swallowing function in patients who underwent hemiglossectomy: comparison of primary closure and free radial forearm flap reconstruction with videofluoroscopy. Ann Plast Surg. 2003;50(5):450-5.
110. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29.
111. Smith JE, Suh JD, Erman A, Nabili V, Chhetri DK, Blackwell KE. Risk factors predicting aspiration after free flap reconstruction of oral cavity and oropharyngeal defects. Arch Otolaryngol Head Neck Surg. 2008;134(11):1205-8.
112. Pauloski BR, Logemann JA, Rademaker AW, McConnel FM, Stein D, Beery Q, et al. Speech and swallowing function after oral and oropharyngeal resections: one-year follow-up. Head Neck. 1994;16(4):313-22.
113. Scherpenhuizen A, van Waes AM, Janssen LM, Van Cann EM, Stegeman I. The effect of exercise therapy in head and neck cancer patients in the treatment of radiotherapy-induced trismus: A systematic review. Oral Oncol. 2015;51(8):745-50.
114. Kotz T, Federman AD, Kao J, Milman L, Packer S, Lopez-Prieto C, et al. Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol Head Neck Surg. 2012;138(4):376-82.
115. Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R. "Pharyngocise": randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):210-9.
116. Carroll WR, Locher JL, Canon CL, Bohannon IA, McColloch NL, Magnuson JS. Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope. 2008;118(1):39-43.
117. Kulbersh BD, Rosenthal EL, McGrew BM, Duncan RD, McColloch NL, Carroll WR, et al. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope. 2006;116(6):883-6.
49
118. Smith GI, Brennan PA, Scott PJ, Ilankovan V. Outcome after radial forearm, gastro-omental, and jejunal free flaps in oral and oropharyngeal reconstruction. Br J Oral Maxillofac Surg. 2002;40(4):330-3.
119. Hsiao HT, Leu YS, Lin CC. Primary closure versus radial forearm flap reconstruction after hemiglossectomy: functional assessment of swallowing and speech. Ann Plast Surg. 2002;49(6):612-6.
120. Xu Z, Zhao XP, Yan TL, Wang M, Wang L, Wu HJ, et al. A 10-year retrospective study of free anterolateral thigh flap application in 872 head and neck tumour cases. Int J Oral Maxillofac Surg. 2015;44(9):1088-94.
121. McConnel FMS, Pauloski BR, Logemann JA, Rademaker AW, Colangelo L, Shedd D, et al. Functional results of primary closure vs flaps in oropharyngeal reconstruction: A prospective study of speech and swallowing. Arch Otolaryngol Head Neck Surg. 1998;124(6):625-30.
122. Uwiera T, Seikaly H, Rieger J, Chau J, Harris JR. Functional outcomes after hemiglossectomy and reconstruction with a bilobed radial forearm free flap. J Otolaryngol. 2004;33(6):356-9.
123. Salibian AH, Allison GR, Krugman ME, Strelzow VV, Brugman JJ, Rappaport I, et al. Reconstruction of the base of the tongue with the microvascular ulnar forearm flap: a functional assessment. Plast Reconstr Surg. 1995;96(5):1081-9; discussion 90-1.
124. Markkanen-Leppanen M, Isotalo E, Makitie AA, Rorarius E, Asko-Seljavaara S, Pessi T, et al. Swallowing after free-flap reconstruction in patients with oral and pharyngeal cancer. Oral Oncol. 2006;42(5):501-9.
125. Wopken K, Bijl HP, van der Schaaf A, Christianen ME, Chouvalova O, Oosting SF, et al. Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer. PLoS One. 2014;9(4):e94879.
126. Lee JH, Machtay M, Unger LD, Weinstein GS, Weber RS, Chalian AA, et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(8):871-5.
127. Scolapio JS, Spangler PR, Romano MM, McLaughlin MP, Salassa JR. Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile? J Clin Gastroenterol. 2001;33(3):215-7.
128. Cheng SS, Terrell JE, Bradford CR, Ronis DL, Fowler KE, Prince ME, et al. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132(6):655-61.
129. Shaw SM, Flowers H, O'Sullivan B, Hope A, Liu LW, Martino R. The effect of prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement on swallowing and swallow-related outcomes in patients undergoing radiotherapy for head and neck cancer: a systematic review. Dysphagia. 2015;30(2):152-75.
130. Lazarus CL, Logemann JA, Pauloski BR, Rademaker AW, Larson CR, Mittal BB, et al. Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res. 2000;43(4):1011-23.
131. Holloway RH. Combined impedance-manometry for the evaluation of esophageal disorders. Current opinion in gastroenterology. 2014;30(4):422-7.
132. Kendall KA, Kosek SR, Tanner K. Quality-of-life scores compared to objective measures of swallowing after oropharyngeal chemoradiation. Laryngoscope. 2014;124(3):682-7.
133. Ferrari S, Copelli C, Bianchi B, Ferri A, Sesenna E. The Bozola flap in oral cavity reconstruction. Oral Oncol. 2012;48(4):379-82.
50
Appendix I: Search Strategy
The following PubMed logic grid was adapted and utilized for all included databases searched,
with search limits consisting of only English and Human studies.
Oral or Oropharyngeal SCC Dysphagia Primary Free Flap Reconstruction
oropharyngeal neoplasms[mh] OR
deglutition
disorders[mh:noexp] OR surgical flaps[mh] OR
oropharyngeal neoplasm*[tw] OR
deglutition disorder*[tw]
OR free tissue flaps[mh] OR
oropharyngeal squamous cell
carcinoma*[tw] OR dysphagi*[tw] OR surgical flap*[tw] OR
oropharyngeal SCC[tw] OR swallow*[tw] OR tissue flap*[tw] OR
oropharyngeal cancer*[tw] OR deglutition[tw] free flap*[tw] OR
oropharyngeal carcinoma[tw] OR tissue graft*[tw] OR
oropharyngeal tumo*[tw] OR microvascular reconstruction*[tw] OR
oropharynx cancer*[tw] OR microsurgical free flap[tw] OR
oropharynx neoplasm*[tw] OR recontruct*[tw]
oropharynx carcinoma*[tw] OR
oropharynx tumo*[tw] OR
oropharynx squamous cell
carcinoma*[tw] OR
oropharynx SCC[tw] OR
mouth neoplasms[mh] OR
mouth neoplasm*[tw] OR
mouth cancer*[tw] OR
mouth carcinoma*[tw] OR
mouth tumo*[tw] OR
mouth SCC[tw] OR
mouth squamous cell carcinoma*[tw]
OR
oral neoplasm*[tw] OR
oral cancer*[tw] OR
oral carcinoma*[tw] OR
oral tumo*[tw] OR
51
oral SCC[tw] OR
oral squamous cell carcinoma*[tw] OR
oral cavity neoplasm*[tw] OR
oral cavity cancer*[tw] OR
oral cavity carcinoma*[tw] OR
oral cavity tumo*[tw] OR
oral cavity SCC[tw] OR
oral cavity squamous cell
carcinoma*[tw] OR
intraoral neoplasm*[tw] OR
intraoral cancer*[tw] OR
intraoral carcinoma*[tw] OR
intraoral tumo*[tw] OR
intraoral SCC[tw] OR
intraoral squamous cell carcinoma*[tw]
Pubmed searched 26/03/2015 => 241
- Search limits: English, Humans
(((oropharyngeal neoplasms[mh] OR oropharyngeal neoplasm*[tw] OR oropharyngeal
squamous cell carcinoma*[tw] OR oropharyngeal SCC[tw] OR oropharyngeal cancer*[tw] OR
oropharyngeal carcinoma[tw] OR oropharyngeal tumo*[tw] OR oropharynx cancer*[tw] OR
oropharynx neoplasm*[tw] OR oropharynx carcinoma*[tw] OR oropharynx tumo*[tw] OR
oropharynx squamous cell carcinoma*[tw] OR oropharynx SCC[tw] OR mouth neoplasms[mh]
OR mouth neoplasm*[tw] OR mouth cancer*[tw] OR mouth carcinoma*[tw] OR mouth
tumo*[tw] OR mouth SCC[tw] OR mouth squamous cell carcinoma*[tw] OR oral neoplasm*[tw]
OR oral cancer*[tw] OR oral carcinoma*[tw] OR oral tumo*[tw] OR oral SCC[tw] OR oral
squamous cell carcinoma*[tw] OR oral cavity neoplasm*[tw] OR oral cavity cancer*[tw] OR
oral cavity carcinoma*[tw] OR oral cavity tumo*[tw] OR oral cavity SCC[tw] OR oral cavity
squamous cell carcinoma*[tw] OR intraoral neoplasm*[tw] OR intraoral cancer*[tw] OR
intraoral carcinoma*[tw] OR intraoral tumo*[tw] OR intraoral SCC[tw] OR intraoral squamous
cell carcinoma*[tw])) AND (deglutition disorders[mh:noexp] OR deglutition disorder*[tw] OR
dysphagi*[tw] OR swallow*[tw] OR deglutition[tw])) AND (surgical flaps[mh] OR free tissue
flaps[mh] OR surgical flap*[tw] OR tissue flap*[tw] OR free flap*[tw] OR tissue graft*[tw] OR
microvascular reconstruction*[tw] OR microsurgical free flap[tw] OR recontruct*[tw])
52
Embase searched 26/03/2015 => 120
- Search limits: English, Humans
(oropharynx tumor'/syn OR 'oropharynx tumor'/exp OR 'oropharynx cancer':ab,ti OR
'oropharynx cancers':ab,ti OR 'oropharynx carcinoma':ab,ti OR 'oropharynx
carcinomas':ab,ti OR 'oropharynx neoplasm':ab,ti OR 'oropharynx neoplasms':ab,ti OR
'oropharynx tumor':ab,ti OR 'oropharynx tumors':ab,ti OR 'oropharynx tumour':ab,ti OR
'oropharynx tumours':ab,ti OR 'oropharynx squamous cell carcinoma':ab,ti OR
'oropharynx squamous cell carcinomas':ab,ti OR 'oropharynx scc':ab,ti OR
'oropharyngeal cancer':ab,ti OR 'oropharyngeal cancers':ab,ti OR 'oropharyngeal
carcinoma':ab,ti OR 'oropharyngeal carcinomas':ab,ti OR 'oropharyngeal
neoplasm':ab,ti OR 'oropharyngeal neoplasms':ab,ti OR 'oropharyngeal tumor':ab,ti OR
'oropharyngeal tumors':ab,ti OR 'oropharyngeal tumour':ab,ti OR 'oropharyngeal
tumours':ab,ti OR 'oropharyngeal squamous cell carcinoma':ab,ti OR 'oropharyngeal
squamous cell carcinomas':ab,ti OR 'oropharyngeal scc':ab,ti OR 'mouth tumor'/syn OR
'mouth tumor'/exp OR 'mouth tumour':ab,ti OR 'mouth tumours':ab,ti OR 'mouth
tumor':ab,ti OR 'mouth tumors':ab,ti OR 'mouth neoplasm':ab,ti OR 'mouth
neoplasms':ab,ti OR 'mouth cancer':ab,ti OR 'mouth cancers':ab,ti OR 'mouth
carcinoma':ab,ti OR 'mouth carcinomas':ab,ti OR 'mouth scc':ab,ti OR 'mouth squamous
cell carcinoma':ab,ti OR 'mouth squamous cell carcinomas':ab,ti OR 'oral tumour':ab,ti
OR 'oral tumours':ab,ti OR 'oral tumor':ab,ti OR 'oral tumors':ab,ti OR 'oral
neoplasm':ab,ti OR 'oral neoplasms':ab,ti OR 'oral cancer':ab,ti OR 'oral cancers':ab,ti OR
'oral carcinoma':ab,ti OR 'oral carcinomas':ab,ti OR 'oral scc':ab,ti OR 'oral squamous
cell carcinoma':ab,ti OR 'oral squamous cell carcinomas':ab,ti OR 'oral cavity
tumour':ab,ti OR 'oral cavity tumours':ab,ti OR 'oral cavity tumor':ab,ti OR 'oral cavity
tumors':ab,ti OR 'oral cavity neoplasm':ab,ti OR 'oral cavity neoplasms':ab,ti OR 'oral
cavity cancer':ab,ti OR 'oral cavity cancers':ab,ti OR 'oral cavity carcinoma':ab,ti OR 'oral
cavity carcinomas':ab,ti OR 'oral cavity scc':ab,ti OR 'oral cavity squamous cell
carcinoma':ab,ti OR 'oral cavity squamous cell carcinomas':ab,ti OR 'intraoral
tumour':ab,ti OR 'intraoral tumours':ab,ti OR 'intraoral tumor':ab,ti OR 'intraoral
tumors':ab,ti OR 'intraoral neoplasm':ab,ti OR 'intraoral neoplasms':ab,ti OR 'intraoral
cancer':ab,ti OR 'intraoral cancers':ab,ti OR 'intraoral carcinoma':ab,ti OR 'intraoral
carcinomas':ab,ti OR 'intraoral scc':ab,ti OR 'intraoral squamous cell carcinoma':ab,ti OR
'intraoral squamous cell carcinomas':ab,ti) AND (dysphagi*:de,ab,ti OR 'deglutition
disorder':ab,ti OR 'deglutition disorders':ab,ti OR swallow*:ab,ti OR deglutition:ab,ti) AND
('free tissue graft':de,ab,ti OR 'free tissue graft'/syn OR 'surgical flap':ab,ti OR 'surgical
flaps':ab,ti OR 'free flap':ab,ti OR 'free flaps':ab,ti OR 'tissue graft':ab,ti OR 'tissue
grafts':ab,ti OR 'tissue flap':ab,ti OR 'tissue flaps':ab,ti OR 'microvascular
53
reconstruction':ab,ti OR 'microsurgical free flap':ab,ti OR 'microsurgical free flaps':ab,ti
OR recontruct:de,ab,ti)
CINAHL Searched 26/03/2015 =>12
- Search limits: English, Humans
(MH pharyngeal squamous cell carcinoma* OR AB oropharyngeal squamous cell carcinoma*
OR TI oropharyngeal neoplasm* OR AB oropharyngeal neoplasm* OR TI oropharyngeal
cancer* OR AB oropharyngeal cancer* OR TI oropharyngeal carcinoma* OR AB
oropharyngeal carcinoma* OR TI oropharyngeal tumo* OR AB oropharyngeal tumo* OR TI
oropharynx SCC OR AB oropharynx SCC OR TI oropharynx squamous cell carcinoma* OR
AB oropharynx squamous cell carcinoma* OR TI oropharynx neoplasm* OR AB oropharynx
neoplasm* OR TI oropharynx cancer* OR AB oropharynx cancer* OR TI oropharynx
carcinoma* OR AB oropharynx carcinoma* OR TI oropharynx tumo* OR AB oropharynx tumo*
MH mouth neoplasms OR TI mouth neoplas* OR AB mouth neoplas* OR TI mouth cancer*
OR AB mouth cancer* OR TI mouth carcinoma* OR AB mouth carcinoma* OR TI mouth tumo*
OR AB mouth tumo* OR TI mouth SCC OR AB mouth SCC OR TI mouth squamous cell
carcinoma* OR AB mouth squamous cell carcinoma* OR TI oral neoplas* OR AB oral neoplas*
OR TI oral cancer* OR AB oral cancer* OR TI oral carcinoma* OR AB oral carcinoma* OR TI
oral tumo* OR AB oral tumo* OR TI oral SCC OR AB oral SCC OR TI oral squamous cell
carcinoma* OR AB oral squamous cell carcinoma* OR TI oral cavity neoplas* OR AB oral
cavity neoplas* OR TI oral cavity cancer* OR AB oral cavity cancer* OR TI oral cavity
carcinoma* OR AB oral cavity carcinoma* OR TI oral cavity tumo* OR AB oral cavity tumo*
OR TI oral cavity SCC OR AB oral cavity SCC OR TI oral cavity squamous cell carcinoma*
OR AB oral cavity squamous cell carcinoma* OR TI intraoral neoplas* OR AB intraoral
neoplas* OR TI intraoral cancer* OR AB intraoral cancer* OR TI intraoral carcinoma* OR AB
intraoral carcinoma* OR TI intraoral tumo* OR AB intraoral tumo* OR TI intraoral SCC OR AB
intraoral SCC OR TI intraoral squamous cell carcinoma* OR AB intraoral squamous cell
carcinoma* ) AND ( MH deglutition disorder OR TI deglutition disorder* OR AB deglutition
disorder* OR TI swallow* OR AB swallow* OR TI deglutition OR AB deglutition OR TI
dysphagi* OR AB dysphagi* ) AND ( MH surgical flaps OR TI sugical flap* OR AB surgical
flap* OR TI free tissue flap* OR AB free tissue flap* OR TI tissue flap* OR AB tissue flap* OR
TI free flap* OR AB free flap* OR TI tissue graft* OR AB tissue graft* OR TI microvascular
reconstruction* OR AB microvascular reconstruction* OR TI microsurgical free flap* OR
microsurgical free flap* OR TI recontruct* OR AB recontruct* )
54
Appendix II: Critical Appraisal Instruments
55
56
57
Appendix III: Data Extraction Instruments
58
Appendix IV: Authors Contacted
Archontaki M, Athanasiou A, Stavrianos SD, Korkolis DP, Faratzis G, Papadopoulou F, et al. Functional results
of speech and swallowing after oral microvascular free flap reconstruction. Eur Arch Otorhinolaryngol.
2010;267(11):1771-7.
Barata LF, De Carvalho GB, Carrara-De Angelis E, De Faria JCM, Kowalski LP. Swallowing, speech and quality
of life in patients undergoing resection of soft palate. Eur Arch Otorhinolaryngol. 2013;270(1):305-12.
Brown JS, Rogers SN, Lowe D. A comparison of tongue and soft palate squamous cell carcinoma treated by
primary surgery in terms of survival and quality of life outcomes. Int J Oral Maxillofac Surg. 2006;35(3):208-14.
Brown L, Rieger JM, Harris J, Seikaly H. A longitudinal study of functional outcomes after surgical resection and
microvascular reconstruction for oral cancer: tongue mobility and swallowing function. Journal of Oral &
Maxillofacial Surgery (02782391). 2010;68(11):2690-700.
Gabr EM, Kobayashi MR, Salibian AH, Armstrong WB, Sundine M, Calvert JW, et al. Oromandibular
reconstruction with vascularized free flaps: A review of 50 cases. Microsurgery. 2004;24(5):374-7.
Gabr EM, Kobayashi MR, Salibian AH, Armstrong WB, Sundine M, Calvert JW, et al. Role of ulnar forearm free
flap in oromandibular reconstruction. Microsurgery. 2004;24(4):285-8.
Kalavrezos N, Cotrufo S, Govender R, Rogers P, Pirgousis P, Balasundram S, et al. Factors affecting swallow
outcome following treatment for advanced oral and oropharyngeal malignancies. Head Neck. 2014;36(1):47-54.
Li W, Li R, Safdar J, Huang S, Xu Z, Tan X, et al. Modified visor approach applied to total or subtotal
glossectomy and reconstruction: avoidance of lip splitting and mandibulotomy and cutting off mental nerve.
Tumour Biol. 2014;35(8):7847-52.
Lv M, Shen Y, Li J, Zhang C, Zhu H, Sun J. Immediate reconstruction of soft palate defects after ablative surgery
and evaluation of postoperative function: an analysis of 45 consecutive patients. J Oral Maxillofac Surg.
2014;72(7):1397-406.
Markkanen-Leppanen M, Isotalo E, Makitie AA, Rorarius E, Asko-Seljavaara S, Pessi T, et al. Swallowing after
free-flap reconstruction in patients with oral and pharyngeal cancer. Oral Oncol. 2006;42(5):501-9.
Navach V, Zurlo V, Calabrese L, Massaro MA, Bruschini R, Giugliano G, et al. Total glossectomy with
preservation of the larynx: oncological and functional results. Br J Oral Maxillofac Surg. 2013;51(3):217-23.
Pierre CS, Dassonville O, Chamorey E, Poissonnet G, Riss JC, Ettaiche M, et al. Long-term functional outcomes
and quality of life after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal
cancer. ActaOtolaryngol. 2014;134(10):1086-93.
Vega C, Leon X, Cervelli D, Pons G, Lopez S, Fernandez M, et al. Total or subtotal glossectomy with
microsurgical reconstruction: functional and oncological results. Microsurgery. 2011;31(7):517-23.
Villaret AB, Cappiello J, Piazza C, Pedruzzi B, Nicolai P. Quality of life in patients treated for cancer of the oral
cavity requiring reconstruction: a prospective study. ActaOtorhinolaryngol Ital. 2008;28(3):120-5.
Zafereo ME, Weber RS, Lewin JS, Roberts DB, Hanasono MM. Complications and functional outcomes following
complex oropharyngeal reconstruction. Head Neck. 2010;32(8):1003-11.
Zuydam AC, Lowe D, Brown JS, Vaughan ED, Rogers SN. Predictors of speech and swallowing function
following primary surgery for oral and oropharyngeal cancer. ClinOtolaryngol. 2005;30(5):428-37.
59
Appendix V: Included Studies
Author Method Population Site Stage Type of Resection Flap Outcome
Measures
Time of
Assessment
(Months)
Adjuvant
Therapy
Borggreven3 Prospective
Cohort 54
Oral tongue,
FOM, BOT,
Tonsil, Soft
palate
II, III,
IV
Paramedian mandibular
swing for access
Composite resection with
microvascular soft tissue
transfer
RFFF
Oral and
pharyngeal
transit time
Aspiration (PAS)
6, 12 RT
Chien4 Prospective
Cohort 29
Oral tongue,
BOT T3, T4
Partial or total glossectomy
via mandibulotomy
RFFF
ALTF
Tracheostomy
Dependency
G-tube
Dependency
Aspiration
12 CRT
Farace5 Prospective
Cohort 20 Oral cavity T2, T3
Intraoral soft tissue ablation:
Hemiglossectomy, anterior
pavement ablation
RFFF
ALTF Aspiration 6 Unclear
Haddock105 Retrospective
Case-series 8 Oral tongue III, IV Subtotal or total glossectomy VRAM
Tracheostomy
Dependency
G-tube
Dependency
Aspiration
12 RT
Hartl102 Prospective
Case-series 5
Oral tongue,
BOT IV Subtotal or total glossectomy
RFFF
LDF
RMF
Aspiration 18-83 RT
Hsiao109 Prospective
Case-series 4 Oral tongue T2, T3
Hemiglossectomy +
Mandibulotomy RFFF Oral transit time 6 CRT
60
Keiner18 Prospective
Cohort 150
Oral cavity,
Oropharynx
T2, T3,
T4
Tumor resection through
transoral or lateral
pharyngotomy approach
RFFF
Tracheostomy
Dependency
Aspiration
8-15 RT
Li108 Retrospective
Case-series 51
Oral tongue,
FOM, Gum,
Buccal mucosa
T1, T2,
T3, T4 Unclear ALTF UW-QoL 12-84 CRT
Longo17 Prospective
Cohort 13 Oral tongue T3, T4
Anterior total mobile tongue
resection, subtotal tongue
resection
ALTF
Oral transit time
Tracheostomy
dependency
18 RT
Moerman106 Prospective
Case-series 4
Tonsil, Soft
palate, Lateral
pharyngeal wall
T2, T3 WLE of lateral pharyngeal
wall, RMT, Soft palate RFFF
Tracheostomy
Dependency 8-21 RT
O'Connell6 Prospective
Cohort 20
BOT, Lateral
pharyngeal
wall, Soft palate
III, IV
Lip-splitting incision and
presymphyseal
mandibulotomy
RFFF
Tracheostomy
Dependency
G-tube
dependency
Aspiration (PAS)
12 CRT
Rieger7 Prospective
Cohort 32
BOT, Lateral
pharyngeal
wall, Soft palate
T1, T2,
T3, T4
Lip-splitting incision and
presymphyseal
mandibulotomy
RFFF
Tracheostomy
Dependency
G-tube
dependency
Aspiration (PAS)
Oral and
pharyngeal
transit time
Preoperatively,
1, 6 , 12 CRT
Seikaly8 Prospective
Cohort 18
BOT, Lateral
pharyngeal
wall, Soft palate
III, IV
Oropharynx resection, lip split
incision and parasymphyseal
mandibulotomy
RFFF
G-tube
dependency
Aspiration
1, 6, 9, 12 RT
61
Shin9 Retrospective
Case-series 31 Oral tongue T1, T2
Partial glossectomy
performed through peroral
approach, pull through or
paramedian mandibulotomy
RFFF MDADI 21-91 RT
Winter107 Prospective
Case-series 6 BOT III, IV
Resection of tongue base
with mandibulotomy, per oral
resection or lingual release
RFFF,
RMF UW-QOL 9-56 RT
BOT: Base of tongue; FOM: Floor of mouth; RMT: Retromolar trigone; WLE: Wide local excision; RFFF: Radial forearm free flap; ALFT: Anterolateral thigh
flap; VRAM: Vertical rectus abodminus myocutaneous flap; LDF: Latissimus dorsi flap; RMF: rectus myocutaenous flap; G-tube: Gastrostomy tube; MDADI:
MD Anderson Dysphagia Inventory; UW-QOL: University of Washington Quality of Life Questionnaire; S: Surgery; RT: Radiotherapy; CRT: Chemoradiotherapy
62
Appendix VI: Excluded Studies on Full Text
Review
Reason: Follow up Less than 6/12
Butler CE, Lewin JS. Reconstruction of large composite oromandibulomaxillary defects with free
vertical rectus abdominismyocutaneous flaps. PlastReconstr Surg. 2004;113(2):499-507.
Chepeha DB, Sacco AG, Erickson VR, Lyden T, Haxer M, Moyer J, et al. Oropharyngoplasty with
template-based reconstruction of oropharynx defects. Arch Otolaryngol Head Neck Surg.
2009;135(9):887-94.
Hara I, Gellrich NC, Duker J, Schon R, Nilius M, Fakler O, et al. Evaluation of swallowing function
after intraoral soft tissue reconstruction with microvascular free flaps. Int J Oral Maxillofac Surg.
2003;32(6):593-9.
Joo YH, Hwang SH, Park JO, Cho KJ, Kim MS. Functional outcome after partial glossectomy with
reconstruction using radial forearm free flap. AurisNasus Larynx. 2013;40(3):303-7.
Leymarie N, Karsenti G, Sarfati B, Rimareix F, Kolb F. Modification of flap design for total mobile
tongue reconstruction using a sensitive antero-lateral thigh flap. J PlastReconstrAesthet Surg.
2012;65(7):e169-74.
McConnel FMS, Logemann JA, Rademaker AW, Pauloski BR, Baker SR, Lewin J, et al. Surgical
variables affecting postoperative swallowing efficiency in oral cancer patients: A pilot study.
Laryngoscope [Internet]. 1994; 104(1 i):[87-90 pp.]. Available from:
http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/154/CN-00188154/frame.html.
McConnel FMS, Pauloski BR, Logemann JA, Rademaker AW, Colangelo L, Shedd D, et al.
Functional results of primary closure vs flaps in oropharyngeal reconstruction: A prospective study of
speech and swallowing. Arch Otolaryngol Head Neck Surg. 1998;124(6):625-30.
Panchal J, Potterton AJ, Scanlon E, McLean NR. An objective assessment of speech and swallowing
following free flap reconstruction for oral cavity cancers. Br J Plast Surg. 1996;49(6):363-9.
Pauloski BR, Rademaker AW, Logemann JA, McConnel FMS, Heiser MA, Cardinale S, et al.
Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer. Head Neck.
2004;26(7):625-36.
Pazardzhikliev DD, Shipkov CD, Yovchev IP, Khater RH, Kamishev IS. Functional reconstruction of
subtotal glossectomy defects with radial forearm free flap: case report and review of literature. Folia
Med (Plovdiv). 2012;54(2):60-5.
Schache AG, Lieger O, Rogers P, Kelly A, Newman L, Kalavrezos N. Predictors of swallowing
outcome in patients treated with surgery and radiotherapy for advanced oral and oropharyngeal
cancer. Oral Oncol. 2009;45(9):803-8.
Sinha UK, Young P, Hurvitz K, Crockett DM. Functional outcomes following palatal reconstruction
with a folded radial forearm free flap. Ear Nose Throat J. 2004;83(1):45-8.
Skoner JM, Andersen PE, Cohen JI, Holland JJ, Hansen E, Wax MK. Swallowing function and
tracheotomy dependence after combined-modality treatment including free tissue transfer for
advanced-stage oropharyngeal cancer. Laryngoscope. 2003;113(8):1294-8.
Tsue TT, Desyatnikova SS, Deleyiannis FW, Futran ND, Stack BC, Weymuller EA, et al. Comparison
of cost and function in reconstruction of the posterior oral cavity and oropharynx: free vspedicled soft
tissue transfer (Structured abstract). Archives of Otolaryngology Head and Neck Surgery [Internet].
63
1997; 123(7):[731-7 pp.]. Available from:
http://onlinelibrary.wiley.com/o/cochrane/cleed/articles/NHSEED-21997001038/frame.html
Uwiera T, Seikaly H, Rieger J, Chau J, Harris JR. Functional outcomes after hemiglossectomy and
reconstruction with a bilobed radial forearm free flap. J Otolaryngol. 2004;33(6):356-9.
Vigili MG, Bozza F, Bellussi C, Cerro P, Palma O, Pompei S. Use of microvascular free flaps for base
of the tongue reconstructions: Functional evaluation by videofluoroscopy.
MedecineBiologieEnvironnement. 1997;25(2):163-7.
Reason: Non-FF/Osseous FF
Barata LF, De Carvalho GB, Carrara-De Angelis E, De Faria JCM, Kowalski LP. Swallowing, speech
and quality of life in patients undergoing resection of soft palate. Eur Arch Otorhinolaryngol.
2013;270(1):305-12.
Brown JS, Rogers SN, Lowe D. A comparison of tongue and soft palate squamous cell carcinoma
treated by primary surgery in terms of survival and quality of life outcomes. Int J Oral Maxillofac Surg.
2006;35(3):208-14.
Cheng N, Shou B, Zheng M, Huang A. Microneurovascular transfer of the tensor fascia
latamusculocutaneous flap for reconstruction of the tongue. Ann Plast Surg. 1994;33(2):136-41.
Gehanno P, Guedon C, Barry B, Depondt J, Kebaili C. Advanced carcinoma of the tongue: total
glossectomy without total laryngectomy. Review of 80 cases. Laryngoscope. 1992;102(12 Pt
1):1369-71.
Inoue T, Nagata M, Yukawa H, Ogura M, Fujisawa T, Miyamoto M, et al. Evaluation of postoperative
function in patients undergoing reconstruction following resection of superior and lateral
oropharyngeal cancer: long-term outcomes of reconstruction with the Gehanno method. Int J Oral
Maxillofac Surg. 2012;41(1):9-16.
Kobayashi W, Kobayashi M, Hirota W, Kado K, Fukui R, Sato H, et al. Reconstruction of the floor of
the mouth using free jejunal grafts. Asian Journal of Oral and Maxillofacial Surgery. 2002;14(4):190-
6.
Lv M, Shen Y, Li J, Zhang C, Zhu H, Sun J. Immediate reconstruction of soft palate defects after
ablative surgery and evaluation of postoperative function: an analysis of 45 consecutive patients. J
Oral Maxillofac Surg. 2014;72(7):1397-406.
Mowry SE, Ho A, Lotempio MM, Sadeghi A, Blackwell KE, Wang MB. Quality of life in advanced
oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope.
2006;116(9):1589-93.
Pierre CS, Dassonville O, Chamorey E, Poissonnet G, Riss JC, Ettaiche M, et al. Long-term
functional outcomes and quality of life after oncologic surgery and microvascular reconstruction in
patients with oral or oropharyngeal cancer. ActaOtolaryngol. 2014;134(10):1086-93.
Robertson MS, Robinson JM, Horsfall RM. A technique of tongue reconstruction following near-total
glossectomy. J Laryngol Otol. 1987;101(3):260-5.
Rogers SN, Lowe D, Yueh B, WeymullerJr EA. The physical function and social-emotional function
subscales of the University of Washington quality of life questionnaire. Arch Otolaryngol Head Neck
Surg. 2010;136(4):352-7.
Salibian AH, Allison GR, Armstrong WB, Krugman ME, Strelzow VV, Kelly T, et al. Functional
hemitongue reconstruction with the microvascular ulnar forearm flap. PlastReconstr Surg.
1999;104(3):654-60.
64
Su WF, Chen SG, Sheng H. Speech and swallowing function after reconstruction with a radial
forearm free flap or a pectoralis major flap for tongue cancer. J Formos Med Assoc.
2002;101(7):472-7.
Sultan MR, Coleman JJ, 3rd. Oncologic and functional considerations of total glossectomy. Am J
Surg. 1989;158(4):297-302.
Tiwari R, Karim AB, Greven AJ, Snow GB. Total glossectomy with laryngeal preservation. Arch
Otolaryngol Head Neck Surg. 1993;119(9):945-9.
Tiwari R, Snow GB. Role of myocutaneous flaps in reconstruction of the head and neck. J Laryngol
Otol. 1983;97(5):441-58.
Urade M, Igarashi T, Sugi M, Matsuya T, Fukuda T. Functional recovery of swallowing, speech, and
taste in an oral cancer patient with subtotal glossectomy. J Oral Maxillofac Surg. 1987;45(3):282-5.
Urken ML, Buchbinder D, Weinberg H, Vickery C, Sheiner A, Parker R, et al. Functional evaluation
following microvascularoromandibular reconstruction of the oral cancer patient: A comparative study
of reconstructed and nonreconstructed patients. Laryngoscope. 1991;101(9):935-50.
Villaret AB, Cappiello J, Piazza C, Pedruzzi B, Nicolai P. Quality of life in patients treated for cancer
of the oral cavity requiring reconstruction: a prospective study. ActaOtorhinolaryngol Ital.
2008;28(3):120-5.
Yang ZH, Zhang DM, Chen WL, Wang YY, Fan S. Reconstruction of through-and-through oral cavity
defects with folded extended vertical lower trapezius island myocutaneous flap. Br J Oral Maxillofac
Surg. 2013;51(8):731-5.
Zafereo ME, Weber RS, Lewin JS, Roberts DB, Hanasono MM. Complications and functional
outcomes following complex oropharyngeal reconstruction. Head Neck. 2010;32(8):1003-11.
Reason: Incorrect Outcome
Ahmad NA, Margaret L. Anterolateral thigh free flap in reconstruction of Oral cavity malignancy:
Ummc experience. Journal of Health and Translational Medicine. 2008;11(1):33-6.
Airoldi M, Garzaro M, Raimondo L, Pecorari G, Giordano C, Varetto A, et al. Functional and
psychological evaluation after flap reconstruction plus radiotherapy in oral cancer. Head Neck.
2011;33(4):458-68.
Antohi N, Tibirna G, Suharski I, Huian C, Nae S, Stan V, et al. Gastro-omental free flap in
oro/hypopharyngeal reconstruction after enlarged ablative surgery for advanced stage cancer.
Chirurgia (Bucur). 2013;108(4):503-8.
Biglioli F, Brusati R. The folded radial forearm flap in soft-palate and tonsillary fossa reconstruction:
technical note. Int J Oral Maxillofac Surg. 2008;37(1):76-81.
Brown JS, Zuydam AC, Jones DC, Rogers SN, Vaughan ED. Functional outcome in soft palate
reconstruction using a radial forearm free flap in conjunction with a superiorly based pharyngeal flap.
Head Neck. 1997;19(6):524-34.
Brown L, Rieger JM, Harris J, Seikaly H. A longitudinal study of functional outcomes after surgical
resection and microvascular reconstruction for oral cancer: tongue mobility and swallowing function.
Journal of Oral & Maxillofacial Surgery (02782391). 2010;68(11):2690-700.
Bruschi S, Fraccalvieri M, Bussi M, Cavalot A, Ferrero V, Fava R. Reconstruction of the oral cavity
and pharynx with microsurgical flaps after oncological ablation: Our clinical experience.
RivistaItaliana di ChirurgiaPlastica. 2002;34(1-2):47-52.
Bussu F, Salgarello M, Adesi LB, Rigante M, Parrilla C, Guidi ML, et al. Oral cavity defect
reconstruction using anterolateral thigh free flaps. B-ent. 2011;7(1):19-25.
Checcoli E, Bianchini C, Ciorba A, Candiani M, Riberti C, Pelucchi S, et al. Reconstructive head and
neck surgery: oncological and functional results. Tumori. 2013;99(4):493-9.
65
Chen F, Liu J, Lv D, Wang L, Liu Y. Reconstruction of the oropharynx with free posterior tibial flap
after tonsillar cancer extirpation. J Oral Maxillofac Surg. 2014;72(10):2083-91.
Chen WL, Yang ZH, Li JS, Huang ZQ. Reconstruction of the tongue using an extended vertical lower
trapezius island myocutaneous flap after removal of advanced tongue cancer. Br J Oral Maxillofac
Surg. 2008;46(5):379-82.
Cigna E, Rizzo MI, Greco A, De Virgilio A, Palmieri A, Maruccia M, et al. RetromolarTrigone
Reconstructive Surgery: Prospective Comparative Analysis Between Free Flaps. Ann SurgOncol.
2014;22(1):272-8.
Cipriani R, Contedini F, Caliceti U, Cavina C. Three-dimensional reconstruction of the oral cavity
using the free anterolateral thigh flap. PlastReconstr Surg. 2002;109(1):53-7.
de Almeida JR, Park RC, Villanueva NL, Miles BA, Teng MS, Genden EM. Reconstructive algorithm
and classification system for transoraloropharyngeal defects. Head Neck. 2014;36(7):934-41.
de Vicente JC, de Villalaín L, Peña I. Microvascular free tissue transfer for tongue reconstruction
after hemiglossectomy: a functional assessment of radial forearm versus anterolateral thigh flap.
Journal of Oral & Maxillofacial Surgery (02782391). 2008;66(11):2270-5.
Duflo S, Lief F, Paris J, Giovanni A, Thibeault S, Zanaret M. Microvascular radial forearm
fasciocutaneous free flap in hard palate reconstruction. Eur J SurgOncol. 2005;31(7):784-91.
Elsherbiny M, Mebed A, Mebed H. Microvascular radial forearm fasciocutaneous free flap for
palatomaxillary reconstruction following malignant tumor resection. J Egypt NatlCanc Inst.
2008;20(1):90-7.
Engel H, Huang JJ, Lin CY, Lam W, Kao HK, Gazyakan E, et al. A strategic approach for tongue
reconstruction to achieve predictable and improved functional and aesthetic outcomes.
PlastReconstr Surg. 2010;126(6):1967-77.
Gende G. The use of a forehead flap to reconstruct the soft and hard palate after cancer excision. P
N G Med J. 2011;54(1-2):59-62.
Guerin-Lebailly C, Mallet Y, Lambour V, Fournier C, El Bedoui S, Ton Van J, et al. Functional and
sensitive outcomes after tongue reconstruction: about a series of 30 patients. Oral Oncol.
2012;48(3):272-7.
Hara I, Gellrich NC, Duker J, Schon R, Fakler O, Smelzeisen R, et al. Swallowing and speech
function after intraoral soft tissue reconstruction with lateral upper arm free flap and radial forearm
free flap. Br J Oral Maxillofac Surg. 2003;41(3):161-9.
Hsiao HT, Leu YS, Lin CC. Primary closure versus radial forearm flap reconstruction after
hemiglossectomy: functional assessment of swallowing and speech. Ann Plast Surg. 2002;49(6):612-
6.
Hsiao HT, Leu YS, Lin CC. Tongue reconstruction with free radial forearm flap after
hemiglossectomy: a functional assessment. J ReconstrMicrosurg. 2003;19(3):137-42.
Hsiao HT, Leu YS, Liu CJ, Tung KY, Lin CC. Radial forearm versus anterolateral thigh flap
reconstruction after hemiglossectomy: functional assessment of swallowing and speech. J
ReconstrMicrosurg. 2008;24(2):85-8.
Kang HG, Park MC, Lim H, Kim JH, Lee IJ. Modified folding radial forearm flap in soft palate and
tonsillar fossa reconstruction. J Craniofac Surg. 2013;24(2):458-60.
Ko AB, Lavertu P, Rezaee RP. Double bilobed radial forearm free flap for anterior tongue and floor-
of-mouth reconstruction. Ear Nose Throat J. 2010;89(4):177-9.
Koshima I, Hosoda M, Moriguchi T, Kawada S. New multilobe "accordion" flaps for three-dimensional
reconstruction of wide, full-thickness defects in the oral floor. Ann Plast Surg. 2000;45(2):187-92.
66
LaFerriere KA, Sessions DG, Thawley SE, Wood BG, Ogura JH. Composite resection and
reconstruction for oral cavity and oropharynx cancer. A functional approach. Arch Otolaryngol.
1980;106(2):103-10.
Lew DH, Choi EC, Tark KC. Standardization of flap design for oropharyngeal reconstruction after
cancer ablation surgery. Yonsei Med J. 2003;44(6):1078-82.
Longo B, Ferri G, Fiorillo A, Rubino C, Santanelli F. Bilobed perforator free flaps for combined
hemitongue and floor-of-the-mouth defects. J PlastReconstrAesthet Surg. 2013;66(11):1464-9.
McCombe D, Lyons B, Winkler R, Morrison W. Speech and swallowing following radial forearm flap
reconstruction of major soft palate defects. Br J Plast Surg. 2005;58(3):306-11.
McConnel FM, Teichgraeber JF, Adler RK. A comparison of three methods of oral reconstruction.
Arch Otolaryngol Head Neck Surg. 1987;113(5):496-500.
Roh TS, Lee WJ, Choi EC, Koh YW, Lew DH. Radial forearm-palmarislongustenocutaneous free
flap; implication in the repair of the moderate-sized postoncologic soft palate defect. Head Neck.
2009;31(9):1220-7.
Salibian AH, Allison GR, Krugman ME, Strelzow VV, Brugman JJ, Rappaport I, et al. Reconstruction
of the base of the tongue with the microvascular ulnar forearm flap: a functional assessment.
PlastReconstr Surg. 1995;96(5):1081-9; discussion 90-1.
Schliephake H, Jamil MU. Impact of intraoral soft-tissue reconstruction on the development of quality
of life after ablative surgery in patients with oral cancer. PlastReconstr Surg. 2002;109(2):421-30;
discussion 31-2.
Schliephake H, Ruffert K, Schneller T. Prospective study of the quality of life of cancer patients after
intraoral tumor surgery. J Oral Maxillofac Surg. 1996;54(6):664-9; discussion 9-70.
Sharma M, Iyer S, Kuriakose MA, Vijayaraghavan S, Arun P, Sudhir VR, et al. Functional
reconstruction of near total glossectomy defects using composite gastro omental-dynamic gracilis
flaps. J PlastReconstrAesthet Surg. 2009;62(10):1277-80.
Stern JR, Keller AJ, Wenig BL. Evaluation of reconstructive techniques of oropharyngeal defects.
Ann Plast Surg. 1989;22(4):332-6.
Su WF, Hsia YJ, Chang YC, Chen SG, Sheng H. Functional comparison after reconstruction with a
radial forearm free flap or a pectoralis major flap for cancer of the tongue. Otolaryngol Head Neck
Surg. 2003;128(3):412-8.
Tai SR, Won JL, Eun CC, Yoon WK, Dae HL. Radial forearm-palmarislongustenocutaneous free flap;
implication in the repair of the moderate-sized postoncologic soft palate defect. Head Neck.
2009;31(9):1220-7.
Tarsitano A, Vietti MV, Cipriani R, Marchetti C. Functional results of microvascular reconstruction
after hemiglossectomy: free anterolateral thigh flap versus free forearm flap. ActaOtorhinolaryngol
Ital. 2013;33(6):374-9.
Tiwari RM, van Ardenne A, Leemans CR, Quak JJ, Tobi H, Mehta DM, et al. Advanced squamous
cell carcinoma of the base of the tongue treated with surgery and post-operative radiotherapy. Eur J
SurgOncol. 2000;26(6):556-60.
Yokoo S, Komori T, Furudoi S, Shibuya Y, Umeda M, Ichinose A, et al. Indications for vascularized
free rectus abdominismusculocutaneous flap in oromandibular region in terms of efficiency of anterior
rectus sheath. Microsurgery. 2003;23(2):96-102.
Reason: Incorrect Population
Anain SA, Yetman RJ. The fate of intraoral free muscle flaps: is skin necessary? PlastReconstr Surg.
1993;91(6):1027-31.
67
Archontaki M, Athanasiou A, Stavrianos SD, Korkolis DP, Faratzis G, Papadopoulou F, et al.
Functional results of speech and swallowing after oral microvascular free flap reconstruction. Eur
Arch Otorhinolaryngol. 2010;267(11):1771-7.
Bianchi B, Ferri A, Ferrari S, Copelli C, Boni P, Baj A, et al. Reconstruction of lateral through and
through oro-mandibular defects following oncological resections. Microsurgery. 2010;30(7):517-25.
Bianchi B, Ferri A, Ferrari S, Copelli C, Boni P, Sesenna E. Reconstruction of anterior through and
through oromandibular defects following oncological resections. Microsurgery. 2010;30(2):97-104.
Bodin IK, Lind MG, Arnander C. Free radial forearm flap reconstruction in surgery of the oral cavity
and pharynx: surgical complications, impairment of speech and swallowing. ClinOtolaryngol Allied
Sci. 1994;19(1):28-34.
Caliceti U, Piccin O, Sgarzani R, Negosanti L, Fernandez IJ, Nebiaj A, et al. Surgical strategies
based on standard templates for microsurgical reconstruction of oral cavity and oropharynx soft
tissue: a 20 years' experience. Microsurgery. 2013;33(2):90-104.
Chepeha DB, Teknos TN, Shargorodsky J, Sacco AG, Lyden T, Prince ME, et al. Rectangle tongue
template for reconstruction of the hemiglossectomy defect. Arch Otolaryngol Head Neck Surg.
2008;134(9):993-8.
Cocks HC, Kumar BN, Das Gupta AR, Simms MH. Free jejunal patch flaps in oral and oro-
pharyngeal reconstruction. J Laryngol Otol. 1999;113(7):680-2.
Furia CL, Carrara-de Angelis E, Martins NM, Barros AP, Carneiro B, Kowalski LP. Video fluoroscopic
evaluation after glossectomy. Arch Otolaryngol Head Neck Surg. 2000;126(3):378-83.
Gabr EM, Kobayashi MR, Salibian AH, Armstrong WB, Sundine M, Calvert JW, et al. Role of ulnar
forearm free flap in oromandibular reconstruction. Microsurgery. 2004;24(4):285-8.
Gabr EM, Kobayashi MR, Salibian AH, Armstrong WB, Sundine M, Calvert JW, et al. Oromandibular
reconstruction with vascularized free flaps: A review of 50 cases. Microsurgery. 2004;24(5):374-7.
Gellrich NC, Kwon TG, Lauer G, Fakler O, Gutwald R, Otten JE, et al. The lateral upper arm free flap
for intraoral reconstruction. Int J Oral Maxillofac Surg. 2000;29(2):104-11.
Guerin-Lebailly C, Mallet Y, Lambour V, Fournier C, El Bedoui S, Ton Van J, et al. Functional and
sensitive outcomes after tongue reconstruction: about a series of 30 patients. Oral Oncol.
2012;48(3):272-7.
Hartl DM, Kolb F, Bretagne E, Bidault F, Sigal R. Cine-MRI swallowing evaluation after tongue
reconstruction. Eur J Radiol. 2010;73(1):108-13.
Haughey BH. Tongue reconstruction: concepts and practice. Laryngoscope. 1993;103(10):1132-41.
Haughey BH, Taylor SM, Fuller D. Fasciocutaneous flap reconstruction of the tongue and floor of
mouth: outcomes and techniques. Arch Otolaryngol Head Neck Surg. 2002;128(12):1388-95.
Julieron M, Kolb F, Schwaab G, Luboinski B. Reconstruction of the posterior pharyngeal wall after
tumoral resection sparing the larynx. MedecineBiologieEnvironnement. 1997;25(2):149-53.
Kalavrezos N, Cotrufo S, Govender R, Rogers P, Pirgousis P, Balasundram S, et al. Factors
affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
Head Neck. 2014;36(1):47-54.
Kimata Y, Uchiyama K, Ebihara S, Saikawa M, Hayashi R, Haneda T, et al. Postoperative
complications and functional results after total glossectomy with microvascular reconstruction.
PlastReconstr Surg. 2000;106(5):1028-35.
Lazarus C, Husaini H, Jacobson A, Mojica J, Anand S, Urken M. Tongue strength, functional
outcomes and quality of life after oral cancer surgery. Dysphagia. 2012;27(4):602.
Li W, Li R, Safdar J, Huang S, Xu Z, Tan X, et al. Modified visor approach applied to total or subtotal
glossectomy and reconstruction: avoidance of lip splitting and mandibulotomy and cutting off mental
nerve. Tumour Biol. 2014;35(8):7847-52.
68
Lidman D, Niklasson M. Survival and function in patients with tumours of the head and neck operated
on and reconstructed with free flaps. Scand J PlastReconstrSurg Hand Surg. 2008;42(2):77-85.
López-Arcas JM, Arias J, Morán MJ, Navarro I, Pingarrón L, Chamorro M, et al. The Deep Inferior
Epigastric Artery Perforator (DIEAP) Flap for Total Glossectomy Reconstruction. Journal of Oral &
Maxillofacial Surgery (02782391). 2012;70(3):740-7.
Lyos AT, Evans GRD, Perez D, Schusterman MA. Tongue reconstruction: Outcomes with the rectus
abdominis flap. PlastReconstr Surg. 1999;103(2):442-9.
Mah SM, Durham JS, Anderson DW, Irvine RA, Chow C, Fache JS, et al. Functional results in oral
cavity reconstruction using reinnervated versus nonreinnervated free fasciocutaneous grafts. J
Otolaryngol. 1996;25(2):75-81.
Markkanen-Leppanen M, Isotalo E, Makitie AA, Rorarius E, Asko-Seljavaara S, Pessi T, et al.
Swallowing after free-flap reconstruction in patients with oral and pharyngeal cancer. Oral Oncol.
2006;42(5):501-9.
Matloub HS, Larson DL, Kuhn JC, Yousif NJ, Sanger JR. Lateral arm free flap in oral cavity
reconstruction: A functional evaluation. Head Neck. 1989;11(3):205-11.
Mosahebi A, Chaudhry A, McCarthy CM, Disa JJ, Mehrara BJ, Pusic AL, et al. Reconstruction of
extensive composite posterolateral mandibular defects using nonosseous free tissue transfer.
PlastReconstr Surg. 2009;124(5):1571-7.
Navach V, Zurlo V, Calabrese L, Massaro MA, Bruschini R, Giugliano G, et al. Total glossectomy
with preservation of the larynx: oncological and functional results. Br J Oral Maxillofac Surg.
2013;51(3):217-23.
Paydarfar JA, Patel UA. Submental island pedicled flap vs radial forearm free flap for oral
reconstruction: comparison of outcomes. Arch Otolaryngol Head Neck Surg. 2011;137(1):82-7.
Seikaly H, Rieger J, O'Connell D, Ansari K, Alqahtani K, Harris J. Beavertail modification of the radial
forearm free flap in base of tongue reconstruction: technique and functional outcomes. Head Neck.
2009;31(2):213-9.
Seikaly H, Rieger J, Zalmanowitz J, Tang JL, Alkahtani K, Ansari K, et al. Functional soft palate
reconstruction: a comprehensive surgical approach. Head Neck. 2008;30(12):1615-23.
Smith GI, Brennan PA, Scott PJ, Ilankovan V. Outcome after radial forearm, gastro-omental, and
jejunal free flaps in oral and oropharyngeal reconstruction. Br J Oral Maxillofac Surg. 2002;40(4):330-
3.
Song XM, Ye JH, Yuan Y, Zhang SY, Jiang HB, Wu YN. Radial forearm free flap for reconstruction of
a large defect after radical ablation of carcinoma of the tongue and floor of the mouth: some new
modifications. ORL J OtorhinolaryngolRelat Spec. 2010;72(2):106-12.
Steinhart H, Iro H. Carcinoma of the posterior pharyngeal wall - Larynx preservation with the radial
forearm flap or transoral resection. Radiology and Oncology. 1997;31(2):190-1.
Vega C, Leon X, Cervelli D, Pons G, Lopez S, Fernandez M, et al. Total or subtotal glossectomy with
microsurgical reconstruction: functional and oncological results. Microsurgery. 2011;31(7):517-23.
Wagner JD, Coleman JJ, 3rd, Weisberger E, Righi PD, Radpour S, McGarvey S, et al. Predictive
factors for functional recovery after free tissue transfer oromandibular reconstruction. Am J Surg.
1998;176(5):430-5.
Weber RS, Ohlms L, Bowman J, Jacob R, Goepfert H. Functional results after total or near total
glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg. 1991;117(5):512-5.
Yagi S, Kamei Y, Nakayama B, Toriyama K, Torii S. A new design for free flap reconstruction of the
tongue and oropharynx. J ReconstrMicrosurg. 2008;24(3):211-9.
Yanai C, Kikutani T, Adachi M, Thoren H, Suzuki M, Iizuka T. Functional outcome after total and
subtotal glossectomy with free flap reconstruction. Head Neck. 2008;30(7):909-18.
69
Yu P. Reinnervated anterolateral thigh flap for tongue reconstruction. Head Neck. 2004;26(12):1038-
44.
Yun IS, Lee DW, Lee WJ, Lew DH, Choi EC, Rah DK. Correlation of neotongue volume changes with
functional outcomes after long-term follow-up of total glossectomy. J Craniofac Surg. 2010;21(1):111-
6.
Zuydam AC, Lowe D, Brown JS, Vaughan ED, Rogers SN. Predictors of speech and swallowing
function following primary surgery for oral and oropharyngeal cancer. ClinOtolaryngol.
2005;30(5):428-37.
Zuydam AC, Rogers SN, Brown JS, Vaughan ED, Magennis P. Swallowing rehabilitation after oro-
pharyngeal resection for squamous cell carcinoma. Br J Oral Maxillofac Surg. 2000;38(5):513-8.
Reason: Incorrect Study Design
Dziegielewski PT, Ho ML, Rieger J, Singh P, Langille M, Harris JR, et al. Total glossectomy with
laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic
review of the literature. Laryngoscope. 2013;123(1):140-5.
Lam L, Samman N. Speech and swallowing following tongue cancer surgery and free flap
reconstruction--a systematic review. Oral Oncol. 2013;49(6):507-24.
Reason: Poster Presentation
Haddock NT, DeLacure MD, Saadeh PB. Less is more: VRAM inset modification in glossectomy
reconstruction. PlastReconstr Surg. 2008;122(2):70e-2e.
Shin YS, Kim WS, Lee HS, Hong HJ, Kim SH, Koh YW, et al. Radiation deteriorates functional
outcome after glossectomy. Otolaryngology - Head and Neck Surgery. 2011;145:177-8.
Bussu F, Almadori G, Parrilla C, Salgarello M, BaroneAdesi L, Micciche F, et al. Evolution of the
surgical approach to oral squamous cell carcinoma in a single institution. Decisive impact of the
improvement of the reconstructive techniques evaluated on a series of 106 patients between 2004
and 2009. RadiotherOncol. 2011;98:S29.
Cho YH, Song CM, Ji YB, Tae K. Functional outcomes after oral tongue cancer surgery:
Determination of optimal reconstruction method. Oral Oncol. 2013;49:S82.
Dedivitis RA. Long term cosmetic and functional results of reconstruction using myocutaneous and
free flaps. Oral Oncol. 2011;47:S20.
O'Connell DA, Reiger J, Dziegielewski PT, Tang JL, Wolfaardt J, Harris JR, et al. Effect of lingual and
hypoglossal nerve reconstruction on swallowing function in head and neck surgery: Prospective
functional outcomes study. Journal of Otolaryngology - Head and Neck Surgery. 2009;38(2):246-54.
Ryuichi Hayashi MD. Surgical treatment for advanced tongue cancer. Oral Oncol. 2011;47:S16.
Shenoy AM, Krishna A, Shenoy P, Premalatha, Rahul, Sharath. Challenges in rehabilitation after
sub-total and total glossectomy with laryngeal preservation. Oral Oncol. 2011;47:S20.
Shockley R, Johnston B, Netterville JL, Rohde SL. Survival and functional outcomes following total
glossectomy. Otolaryngology - Head and Neck Surgery (United States). 2013;149(2):P197.
70
Appendix VII: Dysphagia Risk Stratification Tool
CRT: Chemoradiotherapy, MDADI: MD Anderson Dysphagia Inventory, UW-QoL: University of
Washington Quality of Life Questionnaire, FEES: Fibreoptic endoscopic evaluations of swallowing, VFSS:
Videofluoroscopy swallowing study, PAS: Penetration-aspiration scale
Low Risk Patients
Early Stage (T1 and T2)
No evidence of regional or distant
metastases
No postoperative CRT
High Risk Patients
Late Stage (T3 and T4)
Resections involving
combinations of the BOT,
oral tongue or soft palate
Postoperative CRT
Swallowing exercises pre-
during treatment
Pre-operative Evaluations
Subjective Quality of Life
Questionnaires (MDADI, UW-QoL)
FEES with PAS
Post-operative Evaluations
Subjective Quality of Life
Questionnaires (MDADI, UW-QoL)
FEES with PAS
Post-operative Evaluations
Subjective Quality of Life
Questionnaires (MDADI, UW-QoL)
FEES with PAS
VFSS Every 6 months
Pre-operative Evaluations
Subjective Quality of Life
Questionnaires (MDADI, UW-QoL)
FEES with PAS
VFSS
Dysphagia Risk Stratification Tool